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Abstract:  Nearly 1 billion people suffering from neurological disorders and approximately 
400,000 patients require surgical intervention to repair damaged peripheral nerves every 
year. There is a need, therefore, for three-dimensional synthetic tissues to serve as both 
models and regenerative structures.  Primary human neural cells are not directly obtainable.  
Differentiated, patient specific adult adipocyte stem cells would offer a non-immunogenic, 
abundant source of cells for regenerative implant applications and in vitro models.  How-
ever, mature, differentiated cells are difficult to obtain reproducibly.  Bioprinting is an at-
tractive approach to building 3D tissues.  However, bioinks that transform into stable solids 
in physiologically conducive environments are needed.  Also, cell survival post-printing is 
an issue, and printing processes effect on cell responses need to be investigated.  I devel-
oped a preparation process that allows for continuous, consistent printing of a chitosan-
gelatin (CG) hydrogel that does not require post-processing.  I investigated the effect of 
print bed temperature, feed rate, flow rate, and needle height on fiber sizes.  Further, I 
designed and developed a compact electrical stimulation device to investigate cell response 
post-printing.  I used computer modeling to ensure I obtained a constant electrical field, 
similar to traditional devices.  Using the developed device, I investigated the response and 
expression of β-III-tubulin of human neuroblasts (NBs) and human adipocyte stem cells 
(hASCs) to electrical stimulation and to the bioprinting process, separately and in combi-
nation.  The CG hydrogel was successfully bioprintined:  the bed temperature had the great-
est effect on fiber size (resolution), followed by feed rate and cells were well distributed 
when printed, maintained viability, and no contamination was observed after 5 days.  A 
compact device was designed with a constant electric field that could be maintained sterile 
during microscopic observation for 6 days post-stimulation.  Both NBs and hASCs showed 
differentiation towards a neural lineage when electrically stimulated.  NBs were more sen-
sitive to the printing process than hASCs losing actin polymerization when printed through 
a 34g needle.  Finally, hASCs exhibit significant β-III-tubulin and neuron-like cell mor-
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An estimated 1 billion people suffer from neurological disorders [1] and cost the US nearly $800 
billion US a year (adjusted to 2014 dollars) [2].  While work has long been conducted in animal 
models [3] and in two-dimensional in vitro culture models, there is a need for more complex and 
relevant tools [4-6] to study diseases including Alzheimer’s, Parkinson’s, and debilitating condi-
tions, such as migraines.  In addition, there are an estimated 400,000 procedures to repair peripheral 
nerve damage each year [7], and neural tissue has very little repair capability.  Combined there is a 
significant need for synthetic, 3D tissues utilizing human cells for both in vitro models and regen-
erative applications.   
Neural cells are terminally differentiated, and are non-proliferative.  For many years, sources of 
neural cells for study of physiology, disease, or drug effects were limited to, cancerous neural pre-
cursors, and fetal animal ganglia.  Both sources have limited relevance to normal human neurons 
and are unsuited to neural regeneration applications.   Human stem cells, especially human adult 
stem cells from patients suffering from these diseases, offer the only avenue for the creation of ex 
vivo models to study these diseases and are currently being used for this purpose to determine 
pathways and therefore potential therapeutic molecules to influence these pathways [8].  However, 
in addition to difficulty obtaining mature cells, there is a lack of  
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reproducibility of these results.  This lack could be attributed to multiple factors including the in-
fluence of 3D space, and difficulty scaling these systems to clinical settings. 
In combination with differentiated stem cells, bioprinting cells is seen as an attractive approach to 
spatially locate multiple cell types and build 3D tissues, such as nerves, layer-by-layer.  To accom-
plish this, cells are suspended in biomaterials, which are used as inks to write on various surfaces 
[9-11].  Moreover, by spatially depositing cell laden inks layer-by-layer, bioprinting can create 
reproducible structures.  A variety of bioprinting technologies have been explored.  Among ex-
plored bioprinting technologies, microextrusion bioprinters which extrude viscous polymeric solu-
tions (up to 6x107cP) using a mechanical or pneumatic system, are popular [12-16].  Many open-
source software packages are available that can be used to render 3D designs into forms that can 
be interpreted by the printers [17].  Since seeding cells post-printing would limit the precision of 
placing different cell types in the required spatiotemporal location [18], bioprinting incorporating 
cells into the printing process is of significant interest.  However, a major caveat is the lack of 
biocompatible inks which transform into mechanically stable solids in physiologically conducive 
environments [19].  In addition, cell survival post-printing is an issue.  This issue is attributed to 
unfavorable printing conditions such as solvents and other gelation mechanisms required to me-
chanically stabilize gels, printing temperature, and shear stresses [20, 21]. Current hydrogel inks 
need crosslinking agents (ultraviolet, pH or chemical) to gel (transition from liquid to solid).  I 
propose using, chitosan-gelatin -β-glycerophosphate (2GP) hydrogels, which exhibit thermogela-
tion at physiological temperature (gelation occurs when the temperature is increased to 37 °C.  My 
work focuses on exploring the printability and obtainable resolution of a hydrogel that has a unique 
gelation mechanism and does not require post-processing.  Further, I explore the effect of the bi-
oprinting processes on cellular response to electrical stimulus using two different cell types and a 
compact device.  Cells respond more drastically to electrical stimulus; these responses would be 
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much less evident in the presence of a chemical stimulus.  To examine cell electrical stimulus re-
sponse, I developed a compact device to maintain sterility during observation while isolating the 
electrodes from culture medium.  These activities are grouped into three specific aims.   
1.1 Aim 1: Create a Bioprinting Process for Chitosan-Gelatin-β-glycerophosphate Thermo-
gelling Hydrogel 
The goal of this aim was to evaluate the printability of the chitosan-gelatin-β-glycerophosphate 
hydrogel and the effect of printing on cell viability using a low cost microextrusion printer.  To-
wards this, I investigated i) the effect of concentration of chitosan-gelatin on gelation characteris-
tics, ii) solution preparation steps (centrifugation, mixing, and degassing) on printability and fiber 
formation, iii) the print bed temperature profiles via IR imaging and grid-based assessment using 
thermocouples, iv) the effect of feed rate (10 to 480 cm/min), flow rate (15 to 60 L/min) and 
needle height (70 to 280m) on fiber size and characteristics, and v) the distribution of neuroblasts 
in printed fibers, and the viability after five days in culture.  I used agarose gel to create uniform 
print surfaces to maintain a constant gap with the needle tip.  These results showed that degassing 
the solution, and precooling the solution was necessary for obtaining continuous fibers.  Fiber size 
decreased from 760µm to 243µm as the feed rate increased from 10cm/min to 100cm/min.  Bed 
temperature played the greatest role in fiber size, followed by feed rate.  Cells were well distributed 
within the fibers and exhibited excellent viability and no contamination after 5 days.  Findings are 
described in Chapter III in detail.  
1.2 Aim 2: Develop a Compact Electric Stimulation Device and Test the Response of Neuro-
blasts and Human Adipocyte Stem Cells  
The goal of this aim was to develop and validate a compact electrical stimulation device to assess 
alterations in cell responses to electric fields, similar to traditional devices [22-24].  Three criteria 
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were used in designing a galvanotaxis device: i) obtaining a constant EF so that all cells are sub-
jected to the same stimulus; ii) isolating ionic products generated by the electrodes; and iii) increas-
ing portability while maintaining sterility.  I constrained the overall device dimensions to match 
the footprint of a standard microscope slide (75mm long×25 mm wide, and, 13mm height) so that 
the device is compatible with inverted microscopes.  I tested devices with and without physical 
barriers separating the electrodes from cell culture area, two type of electrodes i.e., point electrodes 
and disk electrodes, and location of the disk electrode on electrical field.  These designs were first 
generated in SolidWorks and then imported into COMSOL simulation to evaluate electrical field 
distribution.  The same design was imported into a 3D printer for manufacturing of the device.  
Based on these analyses, I selected one device for examining whether neuroblasts would respond 
similar to other neural cells when stimulated by exhibiting morphological alignment or galvano-
taxis [23].  Neuroblasts cells were seeded on gelatin coated glass coverslips one or six days prior 
to electrical stimulation.  Cell area, shape factor (circularity), major length, minor length, and cell 
height were determined to quantify morphological changes.  The field effect was evaluated on hu-
man adipocyte stem cells (hASCs) to determine the response of a clinically relevant cell type.  Fur-
ther, some have demonstrated that stimulating cells with an electric field can result in adult stem 
cell differentiation towards a neural lineage [25, 26].  Therefore, in addition to evaluating morpho-
logical changes, I stained some samples for the nucleus with DAPI, for actin with phalloidin, and 
for β-III-tubulin with TUJ1 clone anti-β-III-tubulin antigen to understand potential differentiation 
of both the NB and hASCs towards a neural lineage.  Findings from these studies are described in 
Chapter IV.  
1.3 Aim 3: Evaluate the Effect of Bioprinting and Electrical Stimulation Separately and 
Jointly on NBs and hASCs 
The goal of this aim was to evaluate the combined and separate effect of bioprinting and electrical 
stimulation on NB and hASC response.  Towards this, I investigated morphological changes of 
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NBs and hASCs printed in: i) in medium through a 34g (60 m internal diameter) or 32g needle 
(120 m internal diameter) and ii) mixed into chitosan-gelatin hydrogel.  I also evaluated the con-
ductive properties of the hydrogel to understand changes it could induce in the electrical field.  
Printing conditions were selected from aim 1.  Further, I evaluated changes in morphology of NBs 
stimulated 6 days post printing and hASCs stimulated 1 day after printing, concurrent with aim 2 
results (Chapter IV).  Cell area, shape factor (circularity), major length, minor length, and cell 
height were determined to quantify morphological changes.  In addition, cells were stained for the 
nucleus with DAPI, for actin with phalloidin, and for β-III-tubulin with TUJ1 clone anti-β-III-tu-
bulin antigen to understand potential differentiation of both the NBs and hASCs towards a neural 
lineage and whether the printing process, electrical stimulation, or both altered expression of β-III-
tubulin, which would indicate a difference in differentiation.  I cultured these cells up to six days 
post-printing and show that printed hASCs differentiate towards neurons using beta-III tubulin and 
actin.  These cells showed an increase in beta-III tubulin expression when analyzed immediately 
after printing and when cultured an additional 6-days.  Findings from these studies are described in 
Chapter V.  
1.4 Summary 
This investigation focused on evaluating a novel bioprinter ink with a unique gelation mechanism.  
I demonstrated that multi-level structures can be printed from cell laden CG hydrogels.  Further, I 
evaluated and demonstrated that the temperature and gelation of the hydrogel had the greatest effect 
on fiber size.  These results give needed insight into a previously unexplored gelation mechanism:  
irreversible thermal gelation with increasing temperature and some of the challenges and ad-
vantages of printing hydrogels with this gelation mechanism.  In addition, I find that culture time 
affects cell response differently.  Also, I find that hASCs may differentiate toward a neural lineage 
with electrical stimulation but that the short term shear stress experienced during bioprinting with 
6-day culture significantly increases β-III-tubulin expression.  This indicates that bioprinting might 
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be leveraged for neural differentiation.  These results emphasize the need to evaluate bioprinting 
process effects on cell response and expression to give a more complete picture of the processes’ 
effects, beyond cell viability.  Moreover, these results provide insight into culture time as a factor 
that should be accounted for in stem cell differentiation protocols.  Eventually bioprinting may 
enable the creation of functional 3D pseudo-tissues with spatially controlled multicellular place-
ment.  These tissues could be used for regeneration, as in the case of neural damage that requires 
grafting and exploration of diseases and potential treatments, possibly on a patient-by-patient basis, 








2.1 Tissue Engineering 
Tissue engineering seeks to create synthetic tissues by combining patient cells, typically stem cells 
from a patient, with scaffolds, structures that impart a three-dimensional, relevant geometry, as well 
as cues for differentiation and growth, sufficient porosity for cellular infiltration, and cell binding 
domains for those cells to attach to the scaffold.  Over time, as cells deposit extra cellular matrix 
(ECM), the scaffold degrades and is replaced by ECM.  At the end of the process, a tissue is com-
prised of cells and their generated ECM.  Scaffolds must also be biocompatible and have mechan-
ical properties sufficient to the stresses they experience during and after implantation. 
Moreover, tissue engineering requires stem cells to create complex tissues and organs.  Since many 
cell types are terminally differentiated, small samples cannot be expanded into useful cell numbers.  
However, stem cells are pluripotent progenitors.  With careful culturing, autologous adult stem 
cells can be expanded to useful numbers and then differentiated into non-replicating cell types. 
Therefore, tissue engineering requires both 3D scaffolds to guide cell growth, and well understood 
methods to obtain specific cell types from adult stem cells. This work describes the evaluation of a 
new ink for the creation of these scaffolds and describes the effect the printing process has on cells, 
including differentiation of human adipocyte stem cells, and changes in cell response post printing.  
The work demonstrates the utility of a previously unexplored ink for bioprinting, one that utilizes 
8 
 
a previously unutilized gelation method. Further this work explores a novel compact electrical stim-
ulation device and demonstrates the printing process itself can be used to cause stem cell differen-
tiation towards a neural cell linage, and affects cell response to electrical stimulation. 
2.1.1 Pre-made Scaffolds and Their Limitations 
Many pre-made scaffolds have been investigated and used clinically.  These scaffolds are either 
naturally derived, from decellularized xenogeneic or allogenic sources, produced from synthetic 
polymers, or some combination of the two.  Scaffolds derived from porcine small intestine submu-
cosa and dermis from human, porcine, and bovine sources are clinically available [27]. In multiple 
cases, decellularized cadaver tissue has also been used as grafts.  These scaffolds are either seeded 
exogenously by introducing suspended cells to the scaffold, or implanted without seeding.  This 
allows the endogenous cell population to infiltrate and remodel the tissue post-implantation. 
Most pre-made scaffolds are limited by homogeneity of the source tissue and thickness.  My mas-
ter’s thesis work focused on the development of a scaffold from porcine adipose tissue that main-
tained the source tissue’s inherent vascular network.  Prepared acellular scaffolds, as well as those 
available clinically, are flat sheets.  Forming them into specific geometries is difficult and time 
consuming, requiring a surgeon to suture them into the desired shape; this affects the reliability and 
quality of the regenerated tissue. 
Pre-made scaffolds have been shown to aid in functional peripheral nerve restoration.  Several 
scaffolds from natural polymers, such as collagen, and decellularized nerve tissue have been FDA 
approved for clinical use [28].  These guides are promising and can repair gaps up to 2 cm by 
protecting the nerve tissue from undesirable cell infiltration and providing guidance to the regen-
erating nerve [29].  However, there is a need for guides that can repair longer gaps.  Pre-condition-
ing of scaffolds for nerve guides [30], utilizing Schwann cells combined with external mechanical 
stimulus to pre-align the support-cells [31], and utilizing scaffolds with growth factors and other 
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assistive molecules [32] have been investigated.  More recently, it has been shown that nerve guides 
with multiple micro-channels provide better outcomes:  micro-channels are on the correct scale to 
provide mechanical cues to cells, similar to micro-patterning while also reducing unwanted re-
sponses, such as inflammation.  Producing these scaffolds with the proper size architecture is dif-
ficult and has required new 3D bioprinting technologies [33]. 
2.2 Three-Dimensional Printing 
As it has for other industries, 3D printing has drawn significant interest as a method of precisely 
and economically controlling scaffold geometry.  Significant research has investigated producing 
scaffolds from synthetic polymers, ceramics (specifically for bone), and even metals.  Using data 
obtained from magnetic resonance imaging (MRI) or computed tomography (CT) scanning, a de-
tailed, three-dimensional model of a patient’s bone can be created and used to produce a scaffold 
that precisely fits each, individual patient.  This is known as personalized medicine—people are so 
varied that a ‘one size fits all’ solution often falls far short of the optimum solution.  Therefore, 
using technologies, such as 3D printing, which can quickly and precisely produce patient specific 
solutions is of significant interest.  
2.2.1 3D Printer Hardware 
There are two basic types of 3D printers.  The first deposits material onto a bed through a print 
head.  The second type selectively solidifies material contained in a container from which the final 
part is removed.  All printers have common elements.  First, a microprocessor is required; it must 
be able to take a set of instructions and correctly control the various parts of the printer. Second, 
printers require motors to direct the material or solidifying agent in the x and y directions and a 
motorized system to sequentially move in the Z direction to create additional layers.  Additionally, 




Figure 2.1:  Illustrations of 3D Printers. Diagrams of (a) a FDM printer and (b) a SLA printer 
Fused deposition modeling (FDM) is an example of the first type and is the most common 3D 
printing technology due to inexpensive platforms and material.  An FDM printer consists of a 
heated nozzle mounted to a motion platform that controls movement of the nozzle with respect to 
a build plate.  Plastic, typically acrylonitrile butadiene styrene (ABS) or polylactic acid (PLA), is 
fed from a spool, melted by the nozzle, and deposited on to the build plate in specified patterns, 
creating a part from the bottom up layer-by-layer (Figure 2.1a).  FDM is the least expensive tech-
nology; many do-it-yourself kits exist allowing enthusiasts to build printers for under $1,000 [34].  
The expense and availability of FDM has catalyzed a thriving enthusiast community and the crea-
tion of numerous open source tools and printer designs.  
Stereolithography (SLA) is an example of the second type of printer.  It was the first commercially 
available 3D printing technology (produced by 3D Systems in 1986).  SLA uses a photo initiator, 
either a laser or projector to photolitically crosslink a liquid polymer contained within a bath (Fig-
ure 2.1b).  After each layer is hardened, it is either pulled down into the bath or up out of it, de-
pending on the location of the light source.  Unlike FDM, SLA, and other printers of this second 
type, cannot print parts with hollow, enclosed spaces without encapsulating unhardened material.  
In addition, although SLA printer costs have decreased, they are still costly enough to be limited to 
commercial applications, partly because of the initial printer cost but mostly due to the cost of the 
proprietary liquid polymers required.  However, SLA offers very high resolution (which I define 
as the smallest feature that can be reproduced).  Finally, like FDM, SLA printers are slow, usually 
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because a wiper must spread the liquid across the part each time it is drawn further into the bath.  
However, an exciting new development in SLA technology, called continuous liquid interface pro-
duction (CLIP), has demonstrated vastly greater production speed than previous methods by utiliz-
ing a polymer with an oxygen inhibited photo polymerization reaction and an oxygen permeable, 
optically transparent window in the bottom of the bath.  This window prevents adhesion of cured 
polymer to itself, allowing the part to be built at the bottom of the liquid well and raised out of it 
[35]. 
Selective laser sintering (SLS) is another example of the second type of printer.  It uses a high 
powered laser to melt metal powder, fusing the particles into the desired form.  The particles are 
held in a container and a wiper spreads a new layer of particles over the part after each layer is 
completed and the part is pulled down into the container.  SLS is the only widely used technology 
that can print metals such as steel and aluminum.  However, SLS is one of the most expensive 3D 
printing technologies. 
2.2.2 Controlling a printer with G-Code 
The multi axis motion platform used by most open source printers, utilizes a machine instruction 
language created for automated mills and lathes.  Called G-Code, the language was originally de-
veloped in the 1950s for machine tool computer control.  As CNC mills and lathes have many 
similarities to 3D printers, this language have been adapted for 3D printing [34].  In the course of 
using a 3D printer, the user will rarely, if ever, actually see or write G-Code.  Instead, a 3D model 
is typically converted into G-Code by an accompanying piece of software called a slicer.  Slicers 
generate a series of linear interpolation commands (G1 commands) that move the print head in the 
X and Y axis to deposit the required material for each layer.  The G1 command requires a point 
(given by Cartesian coordinate values X, Y, and Z), an extrusion parameter (E), a feed rate (F), and 
an end stop check command (S), in the form G1 X Y Z E F S.  The command will move the print 
head, called the extruder, along the linear path between its current position and the specified point.  
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Feed rate is a term adopted from milling where it describes the rate material is fed into the milling 
head.  In the case of 3D printers, this parameter is the velocity the extruder moves in relation to the 
print bed.  Extrusion rate on the other hand, is the rate at which material is fed into the extruder as 
a function of distance.  It is a length term, in mm, that specifies the length of filament that will be 
fed into the extruder between the current position and specified position.  Printer commands will 
typically leave off one or more parameters from movement commands, which indicates no move-
ment in that axis (typically the z axis) or to use the previous value in case of the feed rate.  Both 
the Z and F values are commonly missing from movement commands Z changes only between 
layers and F changes only for non-printing moves.  There are numerous other G-Code commands 
utilized by 3D printers; some of the most commonly used commands are listed in Table 2.1. 
Table 2.1:  Common G-Code Commands.  Parameters are followed by numerical values (i.e. 
G1 X120 Y15 Z0.01 E2.56 F1000). See [36] for a g-code reference with detailed documentation 
of many more command parameters 
Command Parameters Action 
; None 
Makes anything to the right of the character on the same 
line a comment, which is ignored by the printer. 
M109 S 
Instructs printer to set temperature and wait until temper-
ature is reached before continuing 
M82 None 
Sets extruder to absolute mode:  E values are related to 
the initial filament position, not the current position 
M101 None Turn extruder on/prepare extruder for printing 
G28 None Home the print head to the origin (X,Y,Z)=(0,0,0) 
G90 None 
Set printer to absolute positioning:  (X,Y,Z) relative to 
origin instead of current position 
G21 None Set units to millimeters 
G20 None Set units to inches 
G92 X Y Z E 
Sets the absolute position at the current location (i.e. G92 
X0 Y0 Z0 E0 would make the current position the 
origin). 
G1 X Y Z E F S 
Straight line move to (X,Y,Z), extrude E mm of material, 
move at feed rate F, and check for end stop S1=yes 
S0=no 
G2 X Y I J E F  
Movement from the current position to (X,Y) along an 
arc centered at (I,J) clockwise while extruding E mm of 
material and moving with feed rate F 
G3 X Y I J E F 
Movement from the current position to (X,Y) along an 
arc centered at (I,J) counterclockwise while extruding E 





Generally, Slicers produce all of the required G-code for printing from 3D models created through 
a variety of means (Figure 2.2).  For complex 3D models, slicers are absolutely necessary to gen-
erate the code required: Figure 2.2c represents almost 250,000 lines of code.  Slicers allow the user 
to change a variety of parameters that affect the printing.  Many of these parameters are determined 
experimentally and vary by material.  Parameters which work well for common materials have been 
found and added into the software to allow users to print good-quality parts without trial-and-error.  
Other parameters are frequently changed based on desired outcomes.  Some important parameters 
include: 1) How much of the part to infill and with what pattern (e.g. fill 50% of the interior volume 
with a honeycomb structure).  Infill allows parts to be printed faster with less material, however it 
reduces mechanical strength.  Further, it is thought that completely filling the interior (100% infill) 
improves the water retention of printed parts.  2) The number of Skirts, which are concentric rings 
printed to establish steady-state flow prior to printing (Figure2.2b and c) show skirts around the 
part). 3) Rafts, which are support material created below a part and can help reduce warping, espe-
cially on unheated print beds). 4) Whether or not to use support material, and the angle past which 
it is required.  This is used to tell the program to generate columns to prevent parts that get larger 
in x and y with z from slumping, and or provide a surface above the build plate on which to print 
(layers can typically be printed up to 45% degrees without support material).  
 
Figure 2.2:  Slicing a model. The initial 3D model (a), visual depiction of material deposited for 
the first layer of the model as described by autogenerated G-Code (b), and a visual representation 
of the 247,000 lines of G-Code generated to build the part (c). 
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2.2.4 3D Printing for Medical Applications: Personalized Medicine 
3D Printing is being widely explored as an avenue to produce personalized devices.  Personalized 
medicine, the concept of addressing individual patients instead of averages, has been shown to be 
more effective.  While one-on-one solutions have required hand shaping in the past, making them 
costly, new technologies are making one-on-one personalized medicine a more widely obtainable 
goal.  Instead of either creating uniform devices modeled around an average patient, or hand craft-
ing each device by hand, 3D printing allows existing designs to be modified slightly for each patient 
or customized designs to be created from CT or MRI scans.  Devices have been historically de-
signed around the average adult male.  This results in devices suited to most male patients but also 
tends to result in devices that are poorly suited to women and especially children. 
So far, a variety of hand prostheses have been 3D printed, the first 3D printed pill has been approved 
by the FDA [37],  a woman’s skull was replaced with a 3D printed implant in the Nederlands [38], 
and research is ongoing on numerous 3D printed devices and 3D printing platforms.  3D printing 
has found its way into hospitals to create 3D, graspable organs and tissues for diagnosis and pre-
planning purposes.  Using 3D printed mimics for pre-surgical planning has shown improved out-
comes in craniofacial and maxillofacial surgeries, and is being applied to many other surgical pro-
cedures [39].  3D printing has also been widely accepted for dental medicine, especially orthodon-
tics  [40].  Medical 3D printing has examined a number of biocompatible polymers including pol-
ycaprolactone (PCL) [41] and blends of PCL and poly-lactic-co-glycolic acid (PLGA) [42].  Over-
all, while 3D printing has had a significant, positive impact on the medical industry, many see 
significantly greater potential for 3D fabrication technologies that is yet to be achieved. 
2.3 Bioprinting 
Both endogenous and exogenous cell population of scaffolds is random.  Cells infiltrate from the 
surrounding environment into the scaffold and their arrangement, distribution, and orientation are 
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either random or factors of the scaffold’s properties (i.e. porosity).  However, tissue morphologies 
are non-random and show distinct arrangement.  The ability to place multiple-cell types in the same 
arrangement as natural tissue morphology is expected to lead to more functional tissues.  3D bi-
oprinting is of significant interest as an avenue to accomplish this by adding cells to inks prior to 
printing.   
2.3.1 Bioprinting Technologies: Advantages and Disadvantages 
Incorporating cells into the 3D printing process is a significant challenge requiring modifications 
to 3D printing technologies developed for non-living materials or the creation of new processes.  
Since cells cannot withstand heating, FDM cannot be used for bioprinting.  However, microextru-
sion printers are a straightforward modification of FDM technology requiring only that the print 
head be modified to feed a liquid polymers extruded at room temperature and crosslinked using 
chemicals, UV light, laser, thermal mechanisms, or by taking advantage of shear thinning materials.  
Modifying a print head requires producing a device to hold a syringe and drive the material.  This 
can be as simple as a mechanical device to drive a syringe plunger or use much more complicated 
systems, depending on the material [43, 44].  The polymer is extruded using a mechanical or pneu-
matic system. For pneumatic systems, the polymer can either be continually extruded or sheared 
into drops using a micro-valve.  Droplet printing is often used to print patterns of cells into a sub-
strate where the end result is the injection of cells into an already present material [45-47].  
SLA translates directly from traditional printing using cells encapsulated in biocompatible, cross-
linkable polymers [48, 49]. SLS systems require photoinitiators and UV light exposure which dam-
ages cells.  Bryant et al. examined several photoinitiators.  Darocur 2959, used to manufacture 
contact lenses, demonstrated the best cytocompatability with cell viability of 75% compared to 
control cultures [50].  This viability is lower than other methods, including microextrusion which 
can demonstrate viabilities near 100% [10].  The greatest advantage offered by SLA is the achiev-
able accuracy.  Accuracies as high as 200 nm have been reported [51]. 
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Two dimensional inkjet technology has also been adapted to 3D printing.  By replacing the ink with 
a hydrogel and adding z axis movement to the print head, a commercial inkjet printer can be con-
verted into a bioprinter.  This technology requires a crosslinking agent to solidify the printed ma-
terial and inks must be non-viscous (less than 10 centipoise) prior to expulsion.  Moreover, there is 
concern that the piezoelectric ejection systems used in inkjet printers might severely decrease cell 
viability.  This problem is increased by the difficulty printing high cell density droplets.  However, 
they are attractive because they are inexpensive and fast [52].  
The last major technology used in bioprinting is laser assisted bioprinting (LAB).  This technology 
uses two parallel surfaces, the upper surface coated with a layer of gold and a layer of cell contain-
ing material.  A laser system pulses specific locations on the upper, donor surface.  When the light 
interacts with the gold layer it is vaporized, creating a localized high pressure region which propels 
the cell containing material onto the receiving surface below (Figure 2.3) [53].  LAB printers have 
a generally low flow rate, are costly, and require changing the donor slide to change cell type or 
material [52]. 
 
Figure 2.3:  Laser Assisted Bioprinting Diagram 
2.3.2 Choosing a Microextrusion Bioprinter 
Ideally, the bioprinting process must maintain cells at physiological condition throughout the pro-
cess.  As shown in Table 2.2, SLS utilizes a bath of polymer crosslinked by UV light, inkjet tech-








and unsuited for large-scale printing.  Because of the viscosity of our hydrogel, and to investigate 
the most economically viable option, I chose to use a microextrusion bioprinter. 
Table 2.2:  Comparison of Bioprinting Processes 
Process Advantages Disadvantages 
Microextrusion  Inexpensive 
 Can handle viscous inks 
 Open Source Platforms 
 Moderate resolution 
 Slow Print Speed 
 
SLA   Very Good Resolution 
 Potentially rapid, printing 
 Requires photo crosslinking 
 Expensive components 
Inkjet  Fast 
 Inexpensive  
 Cannot handle viscous inks 
LAB  Excellent Resolution  Expensive 
 Slow 
 Unsuited to print many layers 
   
2.4 Hydrogels as Inks 
In addition to reducing shear stresses and maintaining cells close to physiological norms, bioprint-
ing processes require non-toxic, biocompatible inks that transition from liquid to solid.  The phase 
transition must also be accomplished without killing the cells in the system. 
2.4.1 Introduction to Hydrogels  
Hydrogels, like tissues, are highly hydrated polymer compounds with unique properties suitable 
for tissue engineering.  Only a fraction of a hydrogel’s weight is contributed by the polymer, some-
times as little as 0.1% [54].  The remainder of the hydrogel is water.  Their water content makes 
them highly permeable, allowing nutrients and waste to diffuse easily into and out of the gel.  Fur-
ther, many hydrogels can be prepared as liquid solutions that undergo phase transition through 
chemical, irradiative, or thermal mechanisms. 
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2.4.2 Hydrogel Mechanical Properties 
Hydrogels can be difficult to handle because they are generally mechanically weak.  However, 
hydrogel mechanical properties are comparable to many soft tissues; mimicking these native me-
chanical properties leads to the best functional outcome [55].  Our hydrogel’s mechanical strength 
can be tuned to match tissue mechanical properties by varying the concentration of polymer, and 
adding crosslinking agents such as hyaluronic acid and transglutaminase.  Thus far, members of 
our laboratory have matched our hydrogel to both cartilage [56] and cardiac tissue [57]. 
2.4.3 Hydrogels in 3D Printing 
3D printing using hydrogels is a recent development; however, hydrogels have gained significant 
interest as bioprinting inks. Early 3D printing results using an alginate hydrogel were published in 
2002 [58].  Cells were incorporated into the printing process using hepatocytes incorporated into 
gelatin crosslinked with glutaraldehyde in 2006 [59]. A literature review suggested sodium alginate 
is still the most commonly used ink (Table 2.3).  Cell printed viabilities range from 68% to 92%.
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    Printed Control   
4 Custom Nozzle HepG2 liver cells Alginate 85±9 — 400 [60] 
 Custom Nozzle   68±6 — 150 [60] 
1 Coaxial nozzle 
Bovine Cartilage Progeni-
tor Cells 
Alginate 92 — 730* [61] 
— 3 ml syringe 
Human fetal cardiomyocyte 
progenitor cells 
Alginate 92 —  [62] 
— Pneumatic syringe 
Mesenchymal Stem Cells 
(MSCs) 
Alginate ~85 — 210-1610 [63] 
— Pneumatic syringe 
Bone Marrow Stromal 
Cells 
















57-70 @ 6 hr — 400-1200 [66] 
— 1 ml Syringe HEK 293FT Gelatin-Alginate 92.25±1.813 — 260 [67] 
— 1 ml Syringe Hela Cells Gelatin-Alginate 90 — 260 [68] 
— — Hepatocytes Gelatin-Chitosan 
>98 inside 
walls 
— — [69] 
6 Syringe hASCs and hTMSCs 
PCL-Decellular-
ized ECM 
>95 @ 24 hr — — [70] 
4 Nozzle C3H/10T1/2, Clone 8 cells 
Gelatin-Methacry-
late 
~60±20 ~78±18 30-200 [71] 
4 Nozzle 























HepG2 Liver Cells 
Gelatin Methac-
rylamide 




HEPG2 and NIH3T3 
Gelatin Methac-
rylamide 
~91±9 ~88±8 500 [72] 
4 10 ml syringe Hepatocytes 
HA, Gelatin and 
atelocollagen 
97.8±1.6 @ 4 
days 
— — [42, 73] 
— Custom Nozzle 




70.1±7.6 @ 48 
hr 
— 300 [74] 
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  Sodium alginate is chemically cross-linked by calcium ions (Ca2+).  Crosslinking is typically ac-
complished by immersion of the structure in a solution of calcium chloride [60-63, 66].  The best 
resolution and viability have been reported using alginate with no viability loss extruding mesen-
chymal stem cells through a 210 µm nozzle [63].  However, calcium is a cell signaling molecule 
and may cause unwanted changes in functionality [75]. As can be seen in Table 2.4, many bioprint-
ing inks require a chemical or irradiative crosslinker.  The exception was spider silk protein. How-
ever, a 70% viability was reported when extruding through a 300µm nozzle [74], much lower than 
for alginate results (~100%) [63] 
Table 2.4:  Gelation mechanisms of investigated Hydrogels. 
Material Gelation Method Ref(s) 
Alginate Calcium Chloride Solution [60-66] 
Alginate-Gelatin Calcium Chloride Solution [67, 68] 





Spider Silk Protein — [74] 
 
In addition, some groups seek to use multi-material hybrid bioprinting processes which utilize tra-
ditional biocompatible polymers, such as PCL, with hydrogels.  In many cases, the hydrogels are 
not cross-linked since the system’s mechanical strength is provided by the polymer [66, 70, 76].  
These systems provide the advantages of PCL and of hydrogel systems.  Utilizing multiple materi-
als in this manner vastly increases production time as the print head must be switched from hydro-
gel to PCL on every layer.  This hybrid approach is restricted bone tissue engineering because the 
mechanical properties of PCL are significantly greater than soft-tissue properties.  
2.4.4 Our Hydrogel 
In contrast, our group has developed a gelatin-chitosan-β-glycerophosphate hydrogel that sponta-
neously transitions from liquid to solid at physiological temperature.  The solution spontaneously 
forms hydrogels at 37C [77]  Our group has demonstrated unique advantages of chitosan in tissue 
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engineering:  chitosan gelatin hydrogels are conducive for adhesion of various cell types [78, 79].  
No post-processing steps are required.  Long-term stability and mechanical properties can be tai-
lored by selectively cross-linking gelatin after gelation using transglutaminase [80, 81], and the 
hydrogel has been shown to be non-immunogenic in a transdermal mouse model. 
2.5 External Stimuli for Cellular Alignment 
Many cells types have distinct, aligned structures in the body.  Nerves, muscles and blood 
vessels are all examples of tissues with aligned cells.  Moreover, cellular alignment in these struc-
tures is often crucial to proper cell function.  One clear example is vascular smooth muscle cell 
contraction. These cells contract uniaxially, and therefore must be aligned concentrically around 
the lumen to cause vasoconstriction. Further, alignment within the cell is important even before the 
first division of an embryo [82].  In the context of tissue engineering, cellular alignment is effected 
by flow induced shear stress, micro-patterns, chemical gradients, mechanical stresses, and electrical 
gradients.  
2.5.1 Shear Stress—Reproducing an Endogenous Environment  
Reproducing in vivo stresses reproduces in vivo morphology—endothelial cells have long 
been known to align in the presence of shear imparted by flow [83].  Similarly, vascular smooth 
muscle cells align perpendicular to fluid flow [84] and cardiomyocites and their fibers align in the 
presence of mechanical loading [85].  This produces a more physiologically relevant cell morphol-
ogy and is usually coupled with positive changes in cytoskeletal arrangement and expression.  For 
example, endothelial cells have been shown to align F-actin stress fibers in the direction of flow 
[86].    
2.5.2 Micro patterns 
Cell alignment via micro patterns has been widely investigated.  Micro-architecture has been cre-
ated through a variety of methods.  Patterns created with selective ultraviolet gelation of cell laden 
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photocurable hydrogels using masks has been shown to align encapsulated human umbilical vein 
endothelial cells, rodent myoblasts, and rodent cardiac side population cells [87], compression 
molding and solvent casting using silicon templates created with lithographic reactive ion etching 
[88], and by electrospinning using a rotating collector plate to create aligned fibers [89].  In addi-
tion, lithographic techniques have been used to create nanoscale patterns [89]. Many of these tech-
niques combine additional signaling, such as patterning the ECM protein laminin in the micro-
grooves. Generally, axon alignment is affected more by pattern depth than width [88]. I will also 
create a hydrogel micro pattern on a coverslip, similar to [87], using bioprinting.  That work pro-
vides a non-shear example of a similar setup utilizing a different gel. However, the work also found 
that significant cellular alignment only occurred in hydrogel fibers with widths of 50-100 µm, 
which needs to be considered.  In addition, significant work has been conducted on neural align-
ment in grooves.  Neurites, immature axonal growths typically from ‘young’ axons isolated from 
unborn rat pups, tend to align with laminin patterned in grooves [88]. 
I investigate micro-architecture similar to that of cast, parallel hydrogel fibers through bioprinting.  
These size of these fibers compared to those investigated by others need to be kept in mind during 
investigation.  It is worth noting that fiber sizes greater than 200 µm failed to elicit alignment from 
cells in hydrogels [87] and alignment pattern widths are usually in the tens of microns; many bi-
oprinted fibers are well over 200 µm. Therefore, the effect of patterning with a bioprinting may not 
be significant. 
2.5.3 Chemical Patterns and Gradients 
As mentioned, patterns of laminin, the second most prevalent protein in the basal lamina (part of 
the ECM), have been combined with microgrooves to assist in cell alignment.  Laminin has also 
been patterned without microgrooves using various techniques, typically stereolithographic.  A mi-
crogrooved template created via Stereolithography to localize laminin in a desired pattern and then 
attaching the protein via solvent (cell culture medium/water) evaporation created laminin gradients 
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[90].  Inkjet bioprinting technologies have been used to pattern growth factors onto hydrogel sur-
faces [91].  Many expect that future bioprinting platforms will use multiple technologies—I antic-
ipate the combination of microextrusion to extrude cell-laden hydrogels might be combined with 
injet printing to pattern growth factor gradients onto printed structures.  If this were done in a layer-
by-layer manner, with a sufficiently small layer height, the gradient could be user controlled in all 
three spatial dimensions. 
2.5.4 Mechanical Stress 
Induced stretch, or uniaxial stress has been shown to align cells.  In one case, cells were 
encapsulated in a hydrogel and then the hydrogel was constrained at two of its ends.  It was found 
that Schwann cells created uniaxial stress in the hydrogel and caused alignment within 12 hours 
[31].  Others have shown that recreating the cyclical, uniaxial stress similar to that experienced by 
the heart, aligns cardiomyocytes contained in a hydrogel [85].  Further, cyclical stress causes fibril 
alignment in a tendon construct [92]. 
2.5.5 Cell Alignment During Bioprinting  
It has been shown that cells align and may differentiate after bioprinting [93].  However, due 
to the influence of multiple mechanisms, no more in-depth cause has been determined.  During the 
bioprinting process, cells are experiencing shear stresses in the needle that can be many times those 
experienced by most cells in vivo.  Cells may also respond to created micropatterns, depending on 
their width.  Finally, adhesion can stretch fibers, possibly inducing a residual axonal prestress 
caused by the opposing adhesion and cohesion forces within a stretched fiber deposited on a print-
ing platform.   
2.5.6 Electrical Stimulation 
Electrical stimulation has long been investigated in vivo for a variety of neurological clinical appli-
cations, including treatment for Parkinson’s disease [94].  Moreover, electrical stimulation is 
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known to drive cell movement (cell movement in response to electrical fields is known as galvano-
taxis) for a variety of cell types including neurites, myoblasts, fibroblasts, and epithelial cells [95].  
Endogenous electric fields are present during embryonic development and guide cell arrangement 
and alignment [96].  These fields are also present during wound healing where they direct the ori-
entation and growth of cells [97]. Further, it has been demonstrated that neuronal cells align in the 
presence of electric fields generated by constant direct current in vitro [23]. 
 
Figure 2.4:  A traditional, multicomponent galvanotaxis device. Outer wells isolate electrode 
products from the cell culture chamber while transmitting current 
Traditional devices for in vitro electrical stimulation are cumbersome, consisting of electrolyte 
filled beakers connected to a central cell culture chamber via agar filled tubes (i.e. salt bridges) 
(Figure 2.4).  However, they are also relatively easy to produce utilizing typical laboratory glass-
ware and culture dishes (although a custom made central cell chamber is sometimes utilized) [22-
24, 98].  In addition to the need for multiple components to isolate the electrodes and their electro-
chemical products from cells, most of these devices are open to air, making them non-sterile if 
routine light-microscopic observation is required or they otherwise need to be removed from a 
sterile hood.  This reduces the opportunity for long-term culture.   
To overcome the limitations of these traditional devices, many have sought to utilize electrodes 
placed directly into culture dishes.  Platinum electrodes have been used for both in vivo and in vitro 
electrical stimulation, are biocompatible, and are available for clinical epilepsy treatment [99, 100].  
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Moreover, carbon nanofibers [101] and conductive polymers [102] have been used.  Since the de-
vices are placed directly in the culture medium, care must be taken to ensure evaluation occurs 
where the electric field is constant, and not near electrodes where cells would experience signifi-
cantly different fields [95], and that electrode products do not affect cell response.  In this work, I 
investigate a compact electrical stimulator that miniaturizes the traditional electrical stimulation 
device while still permitting sterile observation and ease of transportation.  Further, I describe a 
device that is produced by 3D printing, which is increasingly routinely available to laboratories, or 
can be obtained at low cost.  
2.6 Stem Cell Differentiation 
Stem cells are cells that have the ability to differentiate into one or more cell types.  Increasing 
understanding of adult stem cell plasticity and the possibility of developing patient-specific, in-
duced pluripotent stem cells has rekindled hope in the development of various tools and therapies 
relevant to health-care.  Moreover, evaluating cellular differentiation in vitro has gained significant 
attention.  As mentioned previously, many cells types are terminally differentiated.  Not only do 
they have extremely limited self-repair capability, but these cells are difficult to obtain and culture 
in vitro because they do not divide.  Stem cells create the opportunity to obtain these cells for in 
vitro culture studies, opening up a world of investigation previously closed off by the inability to 
culture these cells.  Moreover, especially with neural cells, the only source of human neural cells 
is from stem cells and has proven to be a powerful tool.  For example, utilizing adult cells from 
patients with and without various neurodegenerative diseases has indicated that a lack of proper 
neural differentiation may contribute to the disease and has presented a potential therapeutic mol-
ecule [8].  
While work with pluripotent embryonic stem cells has declined significantly due to ethical con-
cerns, multipotent adult stem cells have gained increasing interest.  Adult stem cells can be obtained 
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from most human tissues.  However mesenchymal stem cells (MSCs), obtained from bone marrow, 
and adipocyte stem cells, obtained from adipose tissue are the most investigated due to their mul-
tipotency (ability to differentiate into multiple cell types), and due to ease of harvest without caus-
ing significant harm.  Moreover, human adipocyte stem cells (hASCs) are of particular interest 
because they can be obtained from routine liposuction, an elective procedure routinely undertaken 
for cosmetic purposes, and have shown potency similar to MSCs [6]. 
Stem cell differentiation protocols overwhelmingly utilize chemical signals (Table 2.5), typically 
provided by growth factors, to induce differentiation.  In addition, evidence demonstrates that in-
hibition of  several key Wnt pathways lead to the differentiation of stem cells [103, 104].  These 
pathways, which include the entire Wnt family are often targeted for differentiation of stem cells 
towards numerous lineages, and recent work has supported that Wnt pathways are involved in dif-
ferentiation towards a neural lineage [8].  
Table 2.5:  Human adipocyte differentiation protocols. 
Differentiation Factors Duration Eff, Evaluation Criteria Ref. 
Isobutylmethylxanthine, indomethacin, and in-
sulin 
14 days 20%-25% NSE, NeuN [105] 
Neural basal medium, b-FGF, VEGF, B-27,  
NGF-β 
37 days 89.1±8.67 3 TUJ1 1 [8] 
bFGF, forskolin 14 days - - [104] 
Neurogenic Diff. Medium. & Electrical Stim-
ulation 
10 days - 
Gene Expression: 
Ngn2, NeuroD1, NSE, 
and TAU 
[106] 
Fibroblast and epidermal GFs neurobasal me-
dium followed by NGF-β & BDNF or for-
skolin and heregulin β-1 




B-27, N1, fibroblast, and epidermal GFs fol-
lowed by NGF-β &BDNF or forskolin and 
heregulin β-1 
28 days - TUJ1 2 [107] 
Poly-D Lysin/laminin B-27, FBS, L-Gluta-
mine, none essential amino acid, SB-431542, 
IGF-1 
2 days 83±2.49 3 TUJ1, PAX6 [108] 
Hanging drops 2 days 91.8±0.73 3 TUJ1, PAX6 [108] 
Basic fibroblast growth factor (b-FGF), vascular endothelial growth factor (VEGF), neuronal growth factor β (NGF-
β), growth factor (GF), brain derived neurotrophic factor (BDNF), fetal bovine serum (FBS), Neuron-specific 
enolace (NSE), and insulin-like growth factor (IGF-1).  1. other criteria were used for oligodendrocytes.  2. Many 
used, main focus of paper to show novel detection targets.  3. Flow cytometry for β-III-tubulin/TUJ1 positive cells 
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Based upon evidence that both chemical and electrical signals likely control cell patterning and 
differentiation during embryonic development, some have investigated electrically mediated cell 
differentiation.  Electric stimulation has been shown to improve the differentiation of already fated 
cells:  neural stem cells [109], osteoblasts [4], and cardiomyocytes  [110].  In addition, electrical 
stimulation of embryoid bodies, formed of embryonic stem cells, has been shown to cause signifi-
cant expression of TUJ1/β-III-tubulin, indicating differentiation of the embryoid bodies towards a 
neural cell line, although stem cells not inducted to form embryoid bodies did not show differenti-
ation [111].  Further, human adipocyte stem cells were shown to differentiate toward a neural lin-
eage in the presence of copper and electrical stimulation.  In the case of electrical stimulation alone, 
hASCs showed slight expression of β-III-tubulin 14 days post stimulation.  However, stimulation 
alone failed to cause cells to express MAP2, an indicator of differentiation into mature neurons 
[112]. 
As shown in Table 2.5, TUJ1, which stains for neuron specific β-III-tubulin is widely used to assess 
neuronal differentiation of hASCs.  For this reason, I chose to assess the differentiation towards a 
neural lineage of both human neuroblasts and hASCs using TUJ1. 
I found that electrical stimulation alone slightly promotes hASC differentiation, similar to previous 
work.  However, I also found that stresses imparted during bioprinting hASCs strongly promote 
the expression of β-III-tubulin after 6 days without induction medium. Therefore, I observed dif-
ferentiation much sooner than expected, based upon the length of chemically mediated protocols.  
In addition, I did not use a neuron specific culture medium containing additives such as B-27 at 
any time during the experiment.  This indicates that both electrical and mechanical signals may 
cause differentiation of hASCs, which has been poorly explored compared to chemically mediated 







BIOPRINTED CHITOSAN-GELATIN THERMOSENSITIVE HYDROGELS USING 
AN INEXPENSIVE 3D PRINTER 
 
3.1 INTRODUCTION 
Incorporating cells into the printing process requires a non-toxic, biocompatible ink that transitions 
from a liquid to a solid and maintains cells close to physiological norms.  Hydrogels have been 
attractive candidates because of their high water content and excellent permeability for transport of 
nutrients [113-115].  There have been many attempts to print using hydrogels from natural poly-
mers such as gelatin and alginates [116].  Many studies are very short term (within couple of hours 
of printing) [117]. Many groups use higher concentration (6 to 10% wt/v) of gelatin as the ink to 
print cells which then can form capillaries [18].  Due to their weak stability post-printing, hydrogels 
are prepared after chemically modifications along with post-processing techniques to improve sta-
bility [118-121]  I propose using a chitosan-gelatin (CG) biocompatible ink that allows processing 
in a physiological environment and does not need post-processing.  CG solutions with -glycer-
ophosphate (2GP) spontaneously form hydrogels at body temperature [77]; the solution (pH=7.4) 
remains in the liquid phase at room temperature and irreversibly forms a hydrogel at body temper-
ature.  Chitosan shares many features with glycosaminoglycans present in the extracellular matrix.  
Since chitosan alone does not support cell adhesion, I blend it with gelatin to support cell adhesion 
[122].  The gelatin component promotes cell adhesion in the absence of serum proteins.   
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CG hydrogels are conducive for adhesion of various cell types [78, 79], degrade [123], and phase 
transition into a hydrogel at 37C without needing post-processing [124].  CG blends support ma-
trix synthesis [78], and are non-immunogenic in a mouse-transdermal model [124]. CG blends’ 
mechanical properties can be tailored by altering gelatin concentration and selectively cross-linking 
gelatin post-gelation using transglutaminase (TG) [80, 81], instead of toxic glutaraldehyde. 
In this study, I evaluated CG hydrogels as ink using microextrusion bioprinting technology. My 
custom-built bioprinter is compact, contains a hot plate for gelation of thermosensitive gels, and 
allows sterile processing inside a biosafety cabinet.  Printing at higher resolutions (smaller fiber 
sizes) while maintaining cell viability and decreasing the time required to finish a print are major 
hurdles microextrusion printers face [125].  Hence, I evaluated various printing parameters such as 
speed rate, volumetric flow rate, needle height, temperature distribution and solution composition 
and preparation.  These results show the possibility of printing cell-laden structures using CG with 
high viability even after five days and the suitability of my inexpensive bioprinter for initial eval-
uation of novel bioprinter inks. 
 
3.2 MATERIALS AND METHODS 
3.2.1 Materials 
Low molecular weight chitosan (50 kDa and 75-85% deacetylation), and gelatin (300 bloom, Type 
A, from porcine skin), were purchased from Sigma Aldrich Chemical (St. Louis, MO). β-glycer-
ophosphate (2GP) was purchased from Santa Cruz Biotechnology, Dallas TX.  Vybrant CFDA SE 
Cell Tracer Kit and Live/Dead Cell Vitality Assay Kit (C12 Resazurin/SYTOX) were purchased 
from ThermoFisher Scientific (Waltham, MA).  IMR-32 Neuroblasts, Eagle’s minimum essential 
medium (EMEM), and 0.05% Trypsin-EDTA were purchased from The American Type Culture 




Maker’s Tool Works (MTW, Oklahoma City, OK) kindly donated a motion platform kit which was 
assembled in the laboratory.  Stepper motors control movement of the bed in the x axis and the 
print head in the y and z axes (Figure 3.1a).  According to the manufacturer, the minimum move-
ment resolution (x and y axes) is 12.5µm, the z axis has significantly greater movement resolution.  
A fourth stepper motor (Kysan NEMA 17) depresses the syringe plunger, at a controlled rate, using 
a 5mm linear screw with a minimum step angle of 1.8° and holding torque of 4.7in-lb.  Combined, 
the printer can deposit as little as 0.0043µL of material in a single step.  Sterile, 1mL disposable 
syringes with 34g needles (1/4" long) were used with the print head to maintain sterility.  However, 
the prototype extruder originally provided by MTW had significant problems holding syringes in 
the appropriate orientation during printing.  Hence, the extruder was redesigned to maintain the 
syringe perpendicular to the plate. (Figure 3.1c), printable .STL files of the extruder are available 
in the online version of the article as supplementary material).  Further, to provide a level printing 
substrate, a 1.0% (w/v) agarose solution was prepared and autoclaved for sterilization.  The solution 
was cooled for 10min and 10mL of agarose was aliquoted into 10-cm petri dishes in a sterile hood.  
The dishes were stored at 4°C until use.  Before printing, petri dishes were exposed to UV light to 
eliminate surface contamination. 
 
Figure 3.1.  Bioprinting parts description: a) Complete cell printing setup for printing of cell 




Open source Slic3r software used in conjunction with the printer did not generate models of the 
size and type desired.  Hence, custom Python code was written to start flow and create a multi-
layered square grid (modified from code available at http://www.thingiverse.com/thing:747).  The 
layer height, z offset, skirt radius, number of skirts, fiber spacing, number of fibers, number of 
layers, flow rate, feed rate (both during printing and during movement), and the bed temperature 
are parameters input by the user.  Unless stated otherwise, general printing conditions used were as 
follows: 13 layers were printed 70µm above one another, 4 skirts (initial 50mm diameter) to all 
steady state ink flow, each layer with 20 fibers spaced 1mm apart and successive layers printed 
orthogonally to the layer below.  The feed rate was 100cm/min during printing and 360cm/min 
when not printing, the bed temperature was set to 37°C, and the code moved the print head verti-
cally at the beginning and at the end of the print to avoid collision with the petri dish sidewall. 
The code maintained a consistent flow rate from the extruder (Q) by controlling the distance the 
nozzle moved (L, cm), the feed rate (V, cm/min), and the distance the plunger moved (E, cm).  The 
program continually computed the distance the syringe should be depressed via E = LQ/VAs , 
where 𝐴𝑠 is the cross-sectional area of the inner syringe barrel.  G-code created by the Python script 
was imported into MatterControl, an open source software available from MTW’s website, which 
controlled the printer. 
3.2.4 Preparing and Printing Chitosan-Gelatin Solutions 
Chitosan-gelatin mixtures (from 2 wt% to 4 wt% of each component) in deionized water were 
heated to 120°C for 30 min in a closed container.  Then, 0.4 mL of hydrochloric acid (37%) was 
added per gram of chitosan under sterile conditions.  Since bioinks require uniform solution, a 
sequence of steps were evaluated to obtain uniformity (Figure 3.2a).  First, 1.9 mL was transferred 
to a microcentrifuge tube and centrifuged at 14,000×g for 90s.  The pH was adjusted to 7.4 by 
adding 2GP (0.56% w/v) with a custom sprinkler needle (Figure 3.2b) to evenly distribute 2GP.  
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After mixing, the solution was centrifuged at 3,000×g for 60s (similar to conditions reported for 
epoxy degassing [126]), in some cases cells were encapsulated, the solution loaded into a 1mL 
syringe without introducing air, a 34g needle attached, and the solution cooled for 5 min prior to 
printing. 
Alternately, after the addition of 2GP, vacuum degassing was attempted by placing the open 2mL 
centrifuge tube in a holder and placing the holder in a vacuum desiccator without desiccant.  The 
port on the desiccator was connected to vacuum and the atmosphere drawn down. 
The printer was placed in a biological safety cabinet, cleaned with isopropanol while unpowered 
and exposed to UV light.  Then the syringe assembly was loaded into the printer with the needle 
shield in place to prevent contact between the needle and printer housing.  The presser plate was 
lowered until solution was expelled, the petri dish was moved into place and the Z-datum was 
calibrated to place the needle at the print surface using a small, sterilized Teflon disk with known 
thickness (0.85mm) placed on the print surface:  The needle was lowered until contact was made 
and the Z-datum set 0.85mm below the reported location by altering the z offset parameter in the 
 
Figure 3.2.  Solution Preparation.  (a) Flow scheme various steps involved in preparing CG bio-
inks for consistent printing.  (b) Photograph of a custom needle used to increase homogeneity of 
mixing to distribute 2GP through the hydrogel during mixing.  The needle was created by grind-
ing slots into a 16g hypodermic needle. 
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python code.  Finally, the Teflon disk was removed with sterile forceps and the code was executed 
via the computer interface. 
3.2.5 Analysis of Preparation of Printability 
The effect of each preparation step described on printability (which I define as a combination of 
the duration which a hydrogel can be printed without clogging and fiber continuity) in Figure 3.2a 
was determined by systematic selection of conditions for printing using solutions from each point 
in the process.  Moreover, printability of the resultant hydrogels was quantitatively measured by 
the time during which the material printed (up to completion of one print) and the time at which 
pressure expelled the needle from the syringe.  Three hydrogels were prepared and printed for each 
condition.   
3.2.6 Rheological Analysis of the CG Hydrogel 
Rheology was used to determine the gelation temperature of the hydrogel.  Experiments were con-
ducted on prepared hydrogels using a Discover DHR-3 rheometer (TA Instruments, New Castle, 
DE).  A gap of 150µm was used with a 60mm parallel plate.  Gelation was measured by temperature 
ramp, increasing the temperature from 4°C to 45°C at a rate of 1°C/min while taking oscillatory 
data at 10rad/s with 2% strain.  Data collection continued for 130s after the final temperature was 
reached.  
3.2.7 Heated Bed Temperature Distribution 
To understand the temperature and its distribution on the print surface and ensure it reached the 
gelation temperature, a grid template was created, used for measurement by placing beneath i) the 
agarose substrate used during printing, or ii) 20 mL of water in a petri dish.  The temperature at 
each grid point was measured with a Type K thermocouple connected to a digital display and an 
average was calculated for the grid.  Temperature distribution of the water or agarose was evaluated 
using an IR camera (FLIR ONE).  Thermographic images were captured at each temperature.  
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3.2.8 Morphological Analysis with Light and Scanning Electron Microscopy 
Micrographs of printed structures were obtained using i) light microscopy (AMG EVOS AME-
i2111, Life Technologies, Grand Island, NY) under hydrated conditions and ii) by scanning elec-
tron microscopy (SEM—JEOL 6360, JEOL USA Inc., Peabody, MA) under dry conditions.  Sam-
ples observed by SEM were frozen by immersion in liquid nitrogen followed by lyophilization 
overnight sputter coated with gold for 60s. The SEM specimen stage was tilted at either a 0° or a 
45° angle to obtain depth information for the formed fibers.   
3.2.9 Evaluation of Feed Rate and Needle Height on Fiber Size 
In order to evaluate the effect of feed rate on fiber size, a two-layer grid of fibers was printed with 
varying feed rates.  Fibers were printed sequentially with feed rates of 10, 100, 240, and 480 cm/min 
on both the first and second layer with 3 cm long fibers, inter-fiber spacing of 1cm, and 70µm layer 
height through a 60 µm needle.   
Similarly, a single layer of 3cm long fibers were printed with the needle 70, 140, 280, and 400 µm 
above the print surface to evaluate the effect of needle height on fiber size.   
After printing, fibers were observed under a light microscope (AMG EVOS AME-i2111, Life 
Technologies, Grand Island, NY) and digital micrographs were captured at random locations using 
Micron software.  Fiber sizes were measured using ImageJ (National Institutes of Health).  A min-
imum of 30 measurements were performed per fiber.  The average fiber size and standard deviation 
were calculated (values are reported as average ± standard deviation).  In some cases, the morphol-
ogy of dried fibers was also observed by SEM. 
3.2.10 Culturing IMR-32 Neuroblasts 
IMR-32 neuroblasts (CCL-127) were cultured in EMEM, according to the vendor’s protocol.  Me-
dium was changed three days a week and cells were incubated in a humidified chamber at 37°C, 
5% CO2, 95% air.  When confluent, cells were suspended using 0.5% trypsin-EDTA, pelleted by 
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centrifugation at 125×g for 5 minutes, and re-suspended in fresh medium.  Viable cells were 
counted using a hemocytometer and trypan blue. 
For printing cell-laden fibers, 2×106 cells were pelleted, vortexed, and transferred via pipette into 1 
mL prepared CG solution.  A pipette tip was used to distribute the cells throughout the solution.  
Care was taken not to introduce air bubbles during mixing. 
3.2.11 Cellular Distribution and Viability Analysis 
The distribution of cells in printed fibers was analyzed by pre-staining cells with carboxy-fluores-
cein diacetate, succinimidyl ester (CFDA), similar to our previous publication [57].  In brief, 2×106 
cells were centrifuged (125xg, 5min), suspended in 5mL of 4µM CFDA in PBS, incubated at 37°C 
for 20 minutes, washed in 5mL of PBS and suspended in medium prior to disbursing in the CG 
solution.  Florescent images were captured using Nikon Eclipse TE2000-U inverted microscope 
with attached CCD camera and Prior Scientific Lumen 200 florescence illumination system. 
Separately, 2×106 cells were mixed into 1 mL of hydrogel and printed into cold (4°C) medium to 
determine viability.  As a comparison, cells at the same concentration (2×106 cells/mL) were printed 
in cell culture medium.  All cells were incubated for 5 days with medium changes at day 2 and day 
4 and then suspended.  The culture medium was retained to keep track of unattached cells.  Cells 
were analyzed using the LIVE/DEAD assay kit according to the manufacturer’s protocol, with mi-
nor modifications:  Cells were spun down (125×g for 5 minutes) and the pellet was washed with 
sterile phosphate buffered saline (PBS).  The cells were then suspended in 100µL of PBS containing 
0.1% bovine serum albumin, 500nM C12-resazurin dye, and 20nM SYTOX green dye.  The cells 
were incubated for 15 minutes, transferred to ice, and analyzed immediately, via flow cytometry 
(FACSFlow, BD Biosciences).  Obtained data for each sample were plotted as dot plots where the 
cell populations separate into three groups; Dead cells emit high-level green fluorescence and 
healthy, metabolically active cells emit high-level red fluorescence.  However, injured cells exhibit 
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reduced red and green fluorescence.  Based on this information, percentages of live, injured, and 
dead cells were obtained using a standard quadrant analysis.  The same quadrants were used in all 
conditions.   
 
3.3 RESULTS 
3.3.1 Print Head Deflection 
When printing solutions, many use pneumatic systems which require compressed air to be supplied 
to the print head.  In order to minimize these requirements where additional pneumatic lines have 
to be constructed inside a biosafety cabinet, I used a printer that was applying a simple compressive 
force through a plate.  Code was written where the presser movement is linearly related to the 
dispensed volume.  However, for linear transfer of force from the presser to the solution, other 
resistances have to be minimized.  In this regard, first I evaluated the initial presser plate that was 
provided by the vendor.  When compressive force was applied, both the syringe plunger and presser 
plate experienced unwanted deflection (Figure 3.3a).  The original presser plate (Figure 3.3b) had 
an open back that was intended to clip around linear bearings and lacked support for the syringe 
barrel.  The force exerted on the plate by the plunger was sufficient to unclip the presser plate 
during printing.  Even when secured with a zip tie, the presser plate rotated sufficiently to impart 
deflection to the plunger.  Therefore, the print head was redesigned (Figure 3.3c) to completely 
encompass the linear bearings:  the bearings are inserted from the bottom and held in place by a 
plate with three screws.  In addition, the initial syringe retaining mechanism was too weak to hold 
the syringe when printing and was replaced with a binder clip which allowed for deflection.  The 
second design incorporated a v-shaped channel with a spring loaded bar that retains the 
syringe orthogonal to the presser plate.  Combined with the improved presser plate, the 
redesigned deposition tool held the syringe in a single plane and eliminated bow in the 
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syringe plunger (Figure 3.3d).  The redesign eliminated the source of deflection that did 
not contribute to flow of the solution.  Hence, it minimized the error related to the assump-
tion that fluid flow is linearly proportional to the movement of presser plate. 
 
Figure 3.3.  Comparison of the presser design on the syringe deflection.  (a) Syringe loaded 
into the initial extruder design and clearly showing deflection of the plunger. (b) Original presser 
plate showing the design which allowed the plate to deflect. Redesigned presser plate (c) that, 
combined with the redesign of the mechanism that holds the syringe in place prevents deflection 
in the syringe (d). 
 
3.3.2 Effect of Solution Preparation on Printability 
Solution homogeneity is required to create continuous, uninterrupted fibers.  Initially, hydrogel was 
mixed based on hand printing trials and loaded into a syringe.  During printing, needles clogged 
after short dispensing times and fibers exhibited gaps created by air bubbles.  I hypothesized that 
contaminant solids in the polymer stock solutions blocked the needle due to size mismatch or ag-
gregation, and that prematurely gelled the solution, blocking the needle due to its proximity to the 
heated print surface.  In support of my hypothesis, I observed undissolved particulates present in 
the precursor solution under a stereoscope (not shown) and improved outcomes at lower ambient 
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temperatures.  I investigated centrifugation of the precursor solution to remove particles and cool-
ing of the solution prior to printing to prevent premature gelation.  Further, I investigated two de-
gassing methods:  vacuum degassing and centrifugation.  
To evaluate the separate and combined effect of these methods I set up a series of experi-
ments, shown in Table 3.1.  I examined the general architecture of the structure printed for each 
condition (Figure 3.4a).  I found that combining all of the processes created the structure with the 
fewest defects that was completed without loss of the needle to overpressure which I quantified by 
measuring both the time until flow stopped and the time until the needle was lost to overpressure 
(Figure 3.4b). 
Centrifugation of the solution resulted in visible particulates at the base of the solution and im-
proved print time in a few cases to an average of 98s, still insufficient to begin printing the scaffold 
itself.  Cooling the solution prior to printing demonstrated a significant, positive effect on printa-
bility, increasing print time to an average of 238s, indicating premature gelation was a major factor 
in clogging.   
Vacuum degassing using a vacuum desiccator had no visible effect on the solution and was 
abandoned.  In contrast, centrifugation at 3,000×g for 60s succeeded in removing entrapped air 
bubbles, leaving a semitransparent solution.   
Progressive improvement in fiber continuity and number of fibers that could be printed was 
observed when multiple processing steps were incorporated.  The print time reached a maximum 
time of 325s as determined by a completed print.  At least two of the three prints completed without 
interruption for conditions 6 and 8, indicating that cooling and particle removal prevented clogging.  
Degassing did not affect clogging.  However, it improved the overall architecture as demonstrated 
by the scaffolds for conditions 6 and 8.  Condition 8, a two stage centrifugation protocol with 
cooling resulted in an airless solution that printed consistently and was used throughout the work 
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conducted. Three prints were conducted for each condition 









1    No printing 
2 X   No printing 
3  X  No printing 
4 X X  Improved printing, inconsistent 
5   X 
Unreliable printing for short time 
periods 
6 X  X Improved printing, inconsistent 
7  X X Improved printing, inconsistent 
8 X X X Improved, consistent printing 
 
Figure 3.4:  Effect of solution preparation on printed fiber quality.  a) Photographs of printed 
scaffolds that show the importance of various preparation steps for printing.  b) Printability based 
on print time based upon various preparation steps (n=3).  Numbers correspond to preparations 
detailed in Table 3.1.  Images from processes 2 and 3 did not result in significant printing and 
were omitted.  Each printed scaffold is 2cm × 2cm. 
 
3.3.3 Rheological Determination of Gelation Temperature 
For successful printing of thermosensitive hydrogels, the phase transition must be accomplished 
without affecting cell viability.  Hence, understanding the gelation characteristics is important to 
ensure solutions gel at a survivable temperature.  In particular, addition of gelatin could affect the 
gelation characteristics.  Hence, first I assessed the gelation by performing analysis in a larger sam-
ple of solution.  When cold 3%-3% CG solution (3% w/v chitosan, 3% w/v gelatin) was warmed 
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to 37 C (Figure 3.5), gelation was observed.  The formed hydrogel can be manipulated, by hand, 
as a single piece and the hydrogel was pliable, similar to our previous publication [124].   
 
Figure 3.5:  Photographs of 3% 3% CG solution and hydrogels. (a) Solution at 4C. (b) gela-
tion at physiological condition. (c) Formed hydrogel can be lifted by hand.  (d) Appearance of the 
hydrogel along the thickness when held by fingers. 
 
Next, the effect of chitosan concentration on gelation characteristics was evaluated.  Increased chi-
tosan and gelatin concentration proportionally increased the viscous modulus (Figure 3.6a-c), par-
ticularly at lower temperatures.  When the temperature was increased, elastic modulus increased 
significantly suggesting occurrence of gelation.  Similarly, viscous modulus also increased when 
the temperature raised above the gelation temperature, which ranges from 26°C to 32°C based on 
hydrogel composition.  Increasing chitosan concentration decreased gelation temperature and in-
creased the rate of gelation (Figure 3.6d-e), similar to published reports [127].  At 37 C, rate of 
gelation was near 120s for 2%-2% CG while increasing the concentration to 3%-3% CG formula-
tion gelation rate decreased to less than 60 s.  Increase in rate of gelation with chitosan concentra-
tion is useful for bioprinting, as these factors together could decrease the fiber size.  However, 
modification to the solution resulting in a gelation temperature at or near room temperature is likely 
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to increase the occurrence of premature gelation; this indicates the need for care when increasing 
the chitosan concentration.  
 
Figure 3.6:  Effect of polymer concentration on gelation characteristics.  (a-c) Experiment 
were performed using a temperature ramp run at 1°C/min from 4°C to 47°C with an initial 60s 
soak time and a final 130s soak time.  Data demonstrates onset of gelation. (d-e) Experiment were 
performed using a constant temperature of 37°C to determine gelation time. 
 
3.3.4 Bed Temperature and its Distribution 
The bed temperature needs to be carefully maintained at the gelation temperature determined for 
each solution to allow for proper solution gelation.  Using agarose as the print surface increased 
heat loss between the heating element and print surface.  The temperature of the agarose print sur-
face was approximately 30°C lower than the temperature set for the heated bed.  Figure 3.7a shows 
that the temperature of 20mL of water was similar to that of 10mL of agarose in a 10cm petri dish.  
The temperature distribution (Figure 3.7b) demonstrates the temperature of agarose is more uni-
form across the surface than that of water.  The average temperature of 20mL of deionized water 
(2.5mm thick) in a 10cm petri dish was 35.4°C, the average temperature of 10mL of agarose 
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(1.2mm thick) was 36.0°C.  Irregularities in the temperature profile could attribute to variation in 
gelation rates and the fiber size distribution when thermosensitive hydrogels are used.  
 
Figure 3.7:  Bed temperature characterization.  a) relationship between heat source tempera-
ture (measured by printer) and print surface temperature (measured by type k thermocouple). b) 
Thermal images of 10mL agarose print surface or 20mL water showing the distribution of tem-
perature. 
 
3.3.5 Effect of Feed Rate, Flow Rate, and Bed Temperature on Fiber Diameter 
Understanding the alterations in fiber diameters while maintaining viability is a crucial goal for 3D 
bioprinters.  I hypothesized that adhesion between the fiber and print surface combined with cohe-
sion of the hydrogel may cause thinning as feed rate, the speed with which the needle moves parallel 
to the print surface, increases.  To examine this hypothesis, fibers were printed at different feed 
rates.  The maximum rate (480cm/min) was the manufacturer’s recommendation for polymer print-
ing.  As the feed rate increased, fiber width decreased when fibers were printed on a surface main-
tained at 25°C (Figure 3.8a) or 37°C (Figure 3.8b).  At the slowest feed rate (10cm/min), the 
movement of the print-head was too slow, causing solution to gel in blobs, as observed by large 
deviations indicating these fibers had significant variation in width compared to fibers tested at 
higher velocities.  Blobbing disappeared as movement speed increased.  At 480cm/min, the print 
head was moving fast enough to cause the fiber to lose cohesion and skip in places.  In addition, I 
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observed that increasing the actual bed temperature from 25°C (Figure 3.8a) to 37°C (Figure 3.8b) 
decreased the variability of printed fibers at all feed rates and decreased the fiber diameter when 
printed at 100, and 240cm/min.  However, varying the flow rate at 25°C did not cause any differ-
ence in fiber size.  Temperature has a much greater effect on the fiber size than flow rate, indicating 
that the fiber sizes observed are determined by gelation.   
Figure 3.8:  Box plots showing the effect of printing parameters on fiber size distribution.  
(a) feed rate on fiber size of 3%-3% CG hydrogels printed at a rate of 30µL/min with the agarose 
print surface at 25°C a), b) feed rate on fiber size of 3%-3% CG hydrogels printed at a rate of 
30µL/min with the agarose print surface at 37°C.  c) Effect of flow rate on fiber size at a feed rate 
of 100 cm/min.  box represents the 25th and 75th percentiles, the thick line is the mean of the val-
ues, and the thin line is the median.  n30 in each condition. 
 
3.3.6 Effect of Needle gap 
The distance between the needle and print surface strongly affects the completeness of the resulting 
print.  Since petri dishes lack the flatness tolerance required for bioprinting, distance between the 
needle and print surface could vary significantly from location to location.  In order to minimize 
this variability, agarose gels were formed in the petri dishes on a level surface.  The agarose created 




Figure 3.9:  Effect of needle gap on fiber quality and size.  a) photograph showing the needle 
(34g) position where it initially touches but does not enter the surface of the agarose.  1% DMEM 
powder with phenol red was added to the agarose for contrast.  b) Box plots showing the effect of 
needle height on fiber size distribution. Box represents the 25th and 75th percentiles, the thick line 
is the mean of the values, and the thin line is the median.  n30 in each condition.  c) Scanning 
electron micrographs of fibers printed at different heights. 
 
Setting the needle to touch the agarose on the first layer (Figure 3.9a) allowed printing of contin-
uous fibers. However, setting the needle below the surface of the agarose causes injection of the 
solution into the agarose and may cause premature gelation within the needle.  Setting the gap 
above the surface prevents adhesion between the hydrogel and agarose surface.  Without adhesion, 
large droplets form before their weight overcomes adhesion to the needle and cohesion to the main 
body of hydrogel.  No fibers form in this case.  For traditional 3D printers, the height of the ‘needle’ 
above the print surface is normally fixed only infrequently.  However, using slip tip disposable 
syringes with single use needles and agarose as a print surface, the gap between the needle and the 
surface varies with each newly loaded syringe.  Therefore, the Z datum should be adjusted between 
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each print.  This could be carried out either by changing the initial layer height in the software or 
by using a physical setscrew on the printer.  I chose to use a small, sterilized teflon disk with known 
thickness placed on the agarose surface.  I lowered the needle until contact was made with the 
Teflon disk to determine the height from the surface of the agarose.  The printer was set to begin 
printing at the absolute height of the disk minus its thickness using a parameter within the custom 
code. 
3.3.7 Sterile Printing in Petri Dishes, Viability.  
When printing cell-laden structures, sterility is critical.  My printer is small enough to be placed in 
a conventional 4-ft laminar biosafety cabinet used in routine cell culture.  This allowed us the per-
form the printing process by placing the entire assembly within the biosafety cabinet.  All surfaces 
were disinfected with 70% isopropanol, and irradiated for 20 minutes with the UV lamp present in 
the biosafety cabinet.  A touch screen tablet was used to control the printer and it was mounted on 
the sash of the biosafety cabinet.   
Cells were printed and incubated for five days with continuous monitoring.  No bacterial or fungal 
contamination was observed, suggesting successful sterile printing.  Morphology of cells was sim-
ilar to the unprinted cells (Figure 3.10a).  After five days, viability was analyzed using two-color 
flow cytometry.  These results showed (Figure 3.10b) that neither the flow rates nor feed rates in 




Figure 3.10:  Effect of printing parameters on neuroblast morphology and viability.  a) mi-
crographs of cells printed in medium through the 34g needle showing changes in cell morphology 
when printed at different flow rates and feed rates.  b) Changes in cell viability when printed at 
flow and feed rates conditions identical to micrographs shown in panel (a).   Data represents aver-
age and standard deviations from four independent experiments.  c) & d) Fluorescent micrographs 
showing CFDA-SE stained cells encapsulated in printed Hydrogel fibers.  (c) is parallel fibers ar-
ranged concentrically one-layer high.  d) 12 layers printed on top of one another. 
 
30 mL/min flow rate and 100 cm/min velocity at 140 m nozzle height was greater than 70%.  In 
order to understand the presence of cells within the hydrogel, pre-stained cells were mixed with 
CG solutions and printed at 100 cm/min.  Observation of those cells revealed successful gelation 
and presence of cells within the hydrogel (Figure 3.10c&d).  In addition, the cells were uniformly 
distributed throughout the printed fibers.  Since staining required 20 min incubation of cells at 
37°C, they had to be cooled for 5 min in the refrigeration (4°C) to lower their temperature.  Addition 
of cells directly without cooling resulted in premature gelation which affected printability.  This 




3.3.8 Printed 3D Structure Architecture 
Next, I evaluated the possibility of printing multiple layers.  I successfully printed 13 layers 
using CG solution.  When printed structures were observed under light microscopy in hy-
drated conditions, a nice grid structure mimicking the printed format was observed (Figure 
3.11a).  This suggested the possibility of printing multiple layers using CG solutions.  In 
order to better understand the features of these printed structures and intersections where 
fibers crossed over, samples were analyzed by scanning electron microscopy.  In order to 
not alter the morphology of the fibers, entire printed structure along with the agarose layer 
were analyzed. (Figure 3.11b).  Overall, similar patterns were observed along with the 
smooth agarose layer (Figure 3.11c). Variation in heights across cross-over regions was 
observed, which could be attributed to the sagging when fibers are printed over each other.  
Adding layers atop previously printed layers before they gel can cause them to sag or in-
crease in width.  This could be attributed to the delay in the increase in temperature to that 
needed for gelation.  Increasing the layer height further results in a larger, spread profile 
and encapsulation of previously printed fibers.  Hence, it was difficult to determine all the 
13 layers (Figure 3.11d) even in the cross-sectional view.  In addition, fibers appeared 
more flattened at some regions relative to other regions.  As the rate of gelation decreases, 
the solution requires more time to transform into a hydrogel.  This increases the spreading 
of the polymer solution thereby increasing fiber size.  Further investigation of the polymer 




Figure 3.11:  Morphology of printed 3D structures.  a) Light micrograph of printed CF show-
ing post-printing architecture. SEM micrographs taken at a tilt angle of 45° to show b) scaffold 
overall pore architecture and c) one junction within the architecture. d) Cross-sectional view of 
the scaffold showing the agarose and printed CG hydrogel 
 
3.4 DISCUSSION 
In this study, I show the possibility of using my inexpensive bioprinter in conjunction with CG 
hydrogels to print cell-laden structures with high viability.  A number of bioprinters are commer-
cially available.  My printer cost is less than one-tenth the price of the least expensive commercial 
printer [129, 130].  The printer kit I obtained required user assembly and modification of the plunger 
to accommodate syringes.  In addition, the use of commercially available, disposable hypodermic 
syringes and needles eliminates the need for rigorous cleaning and sterilization protocols to reuse 
expensive metal or glass syringes.  The printer is also compact enough to be retrofitted in any sterile 
hood, easily transferrable when not in use, and is inexpensive at less than $1000 initial investment.  
Others have examined inexpensive printing systems.  A printer from Makers Tool Works has pre-
viously been explored to print synthetic polyester, -polycaprolactone, with a modification to the 
extruder to use plastic beads instead of continuous filament [41].  Python code was used to create 
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custom structure without cells.  Another low cost microextrusion bioprinter modified from a com-
mercial printer was described to inject cells into prefabricated hydrogel using pulled glass pipettes 
[43].  Although this method could allow the precise placement of cells, there was no demonstration 
of controlling the overall hydrogel architecture and they did not investigate the use of hydrogel as 
inks.  Using custom scripts to create scaffolds allowed us to design specific patterns of interest as 
well as control the printer in fine detail.  However, the ease of converting 3D models to g-code and 
printing them directly is lost.  Ideally, a custom slicer would be written that allows the fine control 
of scripting and converts 3D models to g-code.  My results show that my printer is suited to initial 
evaluation of novel inks where a more expensive system represents too much risk.  Our CG hydro-
gel has not previously been investigated as a bioprinter ink and did not justify significant investment 
in technology without evaluation of its suitability as an ink.  Our system allowed that evaluation to 
be conducted without risky investment in more expensive technology. 
I demonstrate a bioprinting technology using CG and -glycerophosphate (2GP), which spontane-
ously forms hydrogels at 37C [77] requiring no post-processing to obtain cell-laden structures.  
Using alginate-based hydrogels and a 210 µm nozzle, mesenchymal stem cells with high viability 
were printed [63].  Alginate forms hydrogels via crosslinking by calcium ions (Ca2+) that are typi-
cally introduced by washing the printed structure with a solution of calcium chloride [60-63, 66].  
There is limited understanding on the effects of modifications on cell processes, controlling the 
fiber size, and the effect of nutrient transport during sustained culture of cells.  Many ink formula-
tions use a combination of gelatin and alginate [67, 68], spider silk protein [74], and gelatin meth-
acrylamide [10, 71, 72].  Most require a chemical or irradiative crosslinker.  Spider silk protein, 
one of the few examples that did not require post-processing, demonstrated 70% viability when 
printed through a 300µm nozzle, while unprinted cell viability, with encapsulation in spider silk 
protein, was 97%.  Our viability results are similar to those.  Nevertheless, various formulations of 
CG can be developed to mimic other matrix elements and mechanical properties.   
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Printer resolution is critical to mimic the structures found in the human body [52].  Increasing 
resolution continues to be a goal for microextrusion bioprinters [131].  Material properties and 
temperature control whether a rounded fiber will slump or remain round.  High viscosity has been 
found to be an important property that a hydrogel needs to possess to prevent slumping [131].  Thus 
I investigated the changes in rheology with concentration of chitosan and gelatin.  Our results 
demonstrated that in CG hydrogels, thermal gelation mechanism needs a greater degree of control:  
ambient temperature, solution temperature, and friction within the needle may all contribute to 
temperature changes and affect gelation.  In addition, presence of air bubbles and impurities affect 
the printability.   
Fibers appear to experience some slumping or under-gelation in which the gelation is occurring too 
slowly to completely separate all fibers from one another, similar to the under-gelation case [128].  
In CG hydrogels, in addition to increasing the polymer concentration, eliminating insulating factors 
to raise the fiber temperature more rapidly may improve the print resolution.  This might be done 
by the addition of pre-warmed media or providing a buoyant force using poloxamers to counteract 
gravitation force.  However, diffusion of the fiber into solution may be an issue.  In addition, rhe-
ological studies are needed for any new polymer concentrations tested to determine the gelation 
temperature in order to prevent premature gelation, and the gelation temperature should also be 
kept above room temperature. 
Overall, the need to pre-cool the syringe, heat loss at the print surface, concentration dependent 
gelation temperature, and temperature dependent gelation rate emphasize the importance of tem-
perature control on fiber characteristics for thermogelling hydrogels.  I expect these results will 
extend to other thermogelling hydrogels investigated as bioprinter inks which are currently un-
derrepresented in bioprinting research.   
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Aguado et al. reported shear thinning hydrogels improved printed cell viability over that of cells 
printed in PBS.   Their hydrogel had a calculated zero shear viscosity of 0.0846 Pa s whereas, my 
hydrogel has a calculated zero shear viscosity of 0.869, an order of magnitude greater [65].  Since 
viscosity is directly related to shear stress (𝜏 = 𝜂
𝑑𝑣
𝑑𝑦
), the shear stress experienced at the wall of 
my needle for similar flow conditions is expected to be significantly greater.  Therefore, a method 
of determining the viability of cells within printed hydrogels is of significant interest.  I have shown 
in the past that gelatin can cleave CFDA and cause fluorescence that obscures any stained cells.  
Therefore, fluorescent microscopy using a LIVE/DEAD kit may not be a viable method of analysis.  
I attempted to analyze the cells and hydrogel via flow cytometry by printing cells within hydrogel 
without heating; intending to cause the dissolution of the hydrogel into medium without allowing 
it to gel.  Printing into cold medium did not result in dissolution of the hydrogel, possibly due to 
gelation of the gelatin within the solution.  Printing the structures and washing with room temper-
ature medium is of interest.  I need to further investigate the effect of flow rate on fiber size to 
determine if a lower flow rate will produce smaller fibers.  Further, I will examine the functionality 
of printed cells by testing their alignment in an electrical field and the effect of co-culturing cells 
with known cell-cell interactions 
As temperature control is the most important factor in my system, increasing the slope of the gra-
dient between the stored and printed hydrogel is expected to improve the system.  Ideally, the hy-
drogel within the needle would be maintained at 4°C, with the printed fiber directly below main-
tained at a consistent 37°C.  I envision water circulated through an aluminum block or sterile tubing 
from an ice bath and isolated from the sterile environment inside the hood to negate heat transfer 
to the hydrogel in the syringe to move the system closer to the stated ideal.  Alternatively, since the 
hydrogel exhibits a semi-gelled state at 4°C, I see maintaining the hydrogel at that temperature and 
then quickly raising the temperature to 37°C possibly using pre-warmed medium.  However, I ex-
pect a loss of hydrogel integrity due to polymer diffusion into the medium.  To prevent this, a dense, 
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pre-warmed biocompatible hydrophobic solution or polymer slurry might be used to quickly raise 
the temperature of the hydrogel, then washed away with PBS and replaced with medium. 
3.5 CONCLUSION 
In this study, I adapted a low cost 3D printer to obtain cell laden structures using CG injectable 
hydrogels.  Further, I evaluated a hydrogel developed in our laboratory using the bioprinter.  I 
demonstrated that solution preparation steps (centrifugation, mixing, and degassing) are important 
in obtaining consistent printability and fiber formation.  Using agarose gel as a print surface allowed 
obtaining uniform print surface to maintain a constant gap with the needle tip.  The fiber size de-
creased from 760µm to 243µm as the feed rate increased from 10cm/min to 100cm/min.  Further, 
I can control the gelation of the hydrogel using heat and gelation process occurs over a short time 
period.  The gel is shear thinning and may protect cells during printing, my printing system does 
not decrease the viability of cells printed in medium compared to the control, and cells were uni-
formly distributed throughout the hydrogel.  I developed a low cost alternative to available bioprint-
ers that will assist researchers in initial evaluation of novel materials for bioprinting without incur-
ring the significant costs imposed by other systems.  Using my inexpensive system, I have shown 







DESIGN AND VALIDATION OF A COMPACT DEVICE FOR IN VITRO ELECTRI-
CAL STIMULATION OF MAMALLIAN CELLS 
 
4.1 Introduction 
Movement of cells due to electrical stimulus, known as galvanotaxis has long been investigated as 
an important factor in the emergence of cell patterns during fetal development [95].  However, 
galvanotaxis devices are bulky, and have multiple components that are difficult to transport while 
maintaining sterility [22-24].  Using one such chamber, and application of 100 mV/mm, rat-bone-
marrow derived stem cells and adipose derived stem cells (hASCs) showed osteogenic differentia-
tion [132].  Some used 200µA of direct current to convert hASCs into osteogenic cells [133].  
Higher voltages applied to hASCs are shown to cause differentiation towards neuronal cells.  
hASCs exposed to an electrical field of nearly 2000mV/mm showed differentiation towards neu-
ronal cells [25].  Cells respond faster and drastically to electrical stimulus than to chemical stimulus. 
Some have converted a 6-well plate into a galvanotaxis device that uses platinum electrodes directly 
immersed into medium [134], or by using carbon electrodes in a petri dish [133].  However, direct 
immersion of electrodes in the vicinity of the cells raises concerns about their effect on cells and 
culture medium.  I sought to engineer a compact device that has the same sterility and portability 
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advantages seen in newer technologies, while recreating the electric field gradient and uniformity 
observed in traditional devices.  With the advances in additive manufacturing, adaptation of 3D 
printing processes in medical science is gaining significant attention. 3D printing technologies can 
be leveraged to create low cost, complex devices for laboratory use. 
In this work, I designed a compact stimulator using computational simulation to obtain a uniform 
electrical field and 3D printed devices of interest.  These devices were easy to transport and main-
tain sterility while performing experiments which required microscopic observation.  I further 
tested the compact device using neuroblasts (NBs) and human adipocyte stem cells (hASCs).  Since 
cells could behave differently, I evaluated the effect of culture duration prior to stimulation.   
4.2 Materials and Methods 
Agarose powder was purchased from Sigma Aldrich Chemical (St. Louis, MO).  IMR-32 Neuro-
blasts, Eagle’s minimum essential medium (EMEM), Fetal Bovine Serum, and 0.05% Trypsin-
EDTA were purchased from The American Type Culture Collection (ATCC – Manassas, VA).  
StemPro Human Adipose-Derived Stem Cells, MesenPRO RS Medium, MesenPRO RS Growth 
Supplement, L-glutamine, Dulbecco's phosphate-buffered saline (DPBS), Alexa Fluor 488 goat-
anti-mouse IgG2a antibodies (A-21131), 4',6-Diamidino-2-Phenylindole, Dihydrochloride (DAPI), 
and Alexa Fluor 546 Phalloidin were purchased from ThermoFisher Scientific (Waltham, MA).  
TUJ1 clone anti-β-III tubulin mouse primary IgG2a antibodies were purchased from Biolegend 
(801201; San Diego, CA).  Ag/AgCl point electrodes were purchased from In Vivo Metrics 
(Healdsburg, CA).  Ag/AgCl disk electrodes (9mm diameter and 1mm thick) were purchased from 
ALA Scientific Instruments (Farmingdale, NY).  Polylactic acid (PLA) printer filament was ob-
tained from MakerBot (New York City, NY).  Silicone adhesive was obtained from Lowes (Stillwa-
ter, OK).  
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4.2.1 Galvanotaxis Device Development 
 
Figure 4.1: Flowchart of the compact device design process  
 
The overall design process for the compact galvanotaxis device is detailed in Figure 4.1.  First, a 
model was created in SolidWorks (Dassault Systems SolidWorks Corporation, Waltham, MA).  
The overall device dimensions were constrained to match the footprint of a standard microscope 
slide (75mm long×25 mm wide, and, 13mm height) so that the device is compatible with inverted 
microscopes.  The device was divided into three chambers, the outer two chambers house the elec-
trodes and a solidified agarose gel to chemically isolate the electrodes from the central chamber 
which houses a coverslip seeded with cells (or with adherent, bioprinted hydrogel) and a window 
for observation via light or fluorescent microscopy (Figure 4.2a).  The central, cell-culture cham-
ber was 25 mm in length.  Two broad designs were considered to separate the cell-culture chamber 
from the two outer electrode chambers and confine agarose during cooling: i) with physical barriers 
(Figure 4.2a) and ii) without physical barriers (Figure 4.2b) to improve conductivity.  Three de-
signs were created with physical barriers and point electrodes (spheres with 2mm diameters) situ-
ated at the center of the outer chambers with holes in both barriers: i) one 3.81 mm hole (Figure 




Figure 4.2:  Two major compact stimulator designs.  a) Model of the electrical stimulator with 
physical walls. b) Cartoon concept drawing of the open stimulator. 
 
A single open design was considered with three different electrode placements: i) against the stim-
ulator floor (Figure 4.4d) and ii) parallel at the same distance as the point electrodes (Figure 4.4e), 
and iii) electrodes located against the outer walls (Figure 4.4f).  In these designs, disk electrodes, 
which spread the current over a larger area unlike the point electrodes, were considered to reduce 
localized heating (Figure 4.3b).  Commercially available disk electrodes, 9mm-diameter and 1mm-
thick, were used.  All designs were imported into either COMSOL for simulation to evaluate the 
expected EF within each device or sent to a 3D printer to manufacture devices.   
4.2.2 Computation Simulation of Electrical Field 
Models were imported from SolidWorks into COMSOL as .stl files.  Import limitations required 
that these devices be imported without holes in the barriers.  After importing the device, holes were 
drawn within COMSOL.  The agarose compartment was considered to have conductivity similar 
to culture medium. Hence, all chambers were considered to be filled with culture medium.  These 
geometries were imported from SolidWorks to fill all three blocks.  For comparison, I modeled a 
previously reported 3-component galvanotaxis device [23] (Figure 4.4g).   
The electrical currents module within COMSOL was used to simulate the initial, steady state elec-
tric field (EF) in each device.  This module was chosen based on COMSOL’s recommendation and 
my interest in the EF generated in the highly conductive, liquid portion of the system.  EF within 
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the system was obtained by considering current to be conserved throughout the model space  using 
the Maxwell Equation •[-σV] = 0.  Electric field was evaluated using the relation E=-V.  The 
electric flux was obtained using Ohm’s law for diffuse media: J = σE + Je where σ is electrical 
conductivity, J is electric flux, Je is current flux generation (zero in my model), and E is the EF.  
Electrical field is related to electric displacement, D, via D = 0rE where r is the dielectric constant 
and 0 is permittivity in vacuum.  A current flux boundary condition calculated to create a 23.4 
mV/mm field across the cell culture portion of each device was assigned to the positive lead.  The 
negative lead was assigned as a ground.   
The electrical conductivity (σ) of cell culture medium was taken as 1.5 S/m and the dielectric con-
stant (r) as 80 [135].  The electrical conductivity of phosphate buffered saline (PBS) was 1.5 S/m 
[136] and the dielectric constant was assumed to also match that of medium.  The agarose was 
assumed to have the same electrical properties as PBS.  The conductivity and dielectric constant of 
PLA material were taken as 7×10-17 S/m and 3.25 respectively [137].  Ag/AgCl electrodes and leads 
were modeled as pure silver with σ as 61.6×106 S/m and the dielectric constant as one. 
All models were meshed with an extra fine free tetrahedral mesh with a maximum element size of 
0.889 mm, a minimum size of 0.22 mm, and a maximum growth rate of 1.35.  The resulting mesh 
had approximately one million nodes.  A mesh independence study was conducted on the electric 
potential at the center of the cell culture chamber, based on the number of mesh elements per volt, 
from 0.5 to 6.5 elements per volt at an interval of 1.0 (element size was defined as 
l
Vn
, where l is 
the distance between electrodes, V is the voltage, and n is the number of elements per volt).  Solu-
tions were found using a well-preconditioned, iterative, conjugate gradients solver.  For each de-
vice, electric potential and the EF lines were generated and all plots were set to the same scale for 
comparison.    
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Based on simulation results, a few prototypes were chosen and printed using polylactic acid (PLA) 
filament in a MakerBot Replicator 5.  A layer height of 0.2mm, with a raft on an unheated build 
plate, with solid infill to decrease porosity and improve liquid retention was used.  A circular trans-
parent window was incorporated into the bottom of the device by attaching an 18mm round micro-
scope coverslip with silicone adhesive.  Electrode placement varied, however permanently placed 
electrodes were also secured with silicone adhesive and wires were insulated with silicone.  Based 
on comparisons between multiple devices, a device without physical barriers was chosen for cell 
culture testing.  Further, additional dams were added to mold micro wells around disc electrodes 
that were filled with medium and would allow gasses to escape without breaking the circuit (Figure 
4.3a).  Disc electrodes were placed against the walls with silicone adhesive and agarose was poured 
to isolate the electrode from culture medium.  To evaluate the effect of agarose concentration in 
the outer chambers on the power required to run the device, 0.5%, 1.0%, and 2.0% (w/v) agarose 
concentrations were used.  Dams were removed after agarose solidified.   
4.2.3 Evaluating Galvanotaxis of Neuroblasts and Adipose Derived Stem Cells 
IMR-32 neuroblasts (CCL-127) and StemPro hASCs were cultured according to the manufacturers’ 
protocols.  Briefly, NBs were cultured in EMEM with 10% FBS.  Medium was changed three times 
per week.  hASCs were cultured in MesenPRO RS medium with 10% Growth supplement and 
2mM L-glutamine.  Medium was changed every 3-4 days.  Both cell types were incubated in a 
humidified chamber at 37°C, 5% CO2, 95% air.  When confluent, NBs were suspended using 0.5% 
trypsin-EDTA, centrifuged at 125×g for 5 minutes, and re-suspended in fresh medium.  When con-
fluent, hASCs were rinsed with Dulbecco’s Phosphate Buffered Saline, and suspended in pre-
warmed TrypLE Express.  Viable cells were counted using a hemocytometer and trypan blue.  
hASCs were used at passage 3.  18mm square microscope coverslips were coated with 0.1% gelatin, 
and air dried in a biosafety cabinet.  After drying, each cover slip was placed in a 6-well plate.  Both 
hASCs and NBs at 22.2×103 cells were pipetted onto the coverslips.  On day 2 or 6 after seeding, 
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a coverslip was transferred into a prepared galvanotaxis device using sterile forceps, and the device 
was placed into a sterile petri dish and wrapped with parafilm.  The stage ring of a Nikon Eclipse 
TE2000-U inverted microscope was replaced with a Nikon Thermo Plate, which was maintained 
at 37 C.  The galvanotaxis device was placed on the thermo plate and cells were continuously 
monitored using the attached CCD camera (Figure 4.3c).  For stimulation, 3 mA direct current was 
applied using a PowerEase® 500 Power Supply (Invitrogen, Carlsbad, CA).  Digital micrographs 
were acquired at 15 min intervals.  Some cultures without pre-stained cells were evaluated via 
immunostaining using both fluorescent microscopy and flow cytometry. 
 
Figure 4.3:  Testing novel galvanotaxis devices.  a)  Parts of the electrical stimulator prior to 
agarose pour.  b)  Various parts of the stimulator with electrodes and agarose. c)  Assembled view 
of electrical stimulation setup.  (d) Appearance of agarose after experimentation with point elec-
trodes and one-hole configuration.  (e) Appearance of agarose after experimentation with disc 
electrodes without physical barrier. 
 
Using digital micrographs, the area, major axis length, minor axis length, and shape factor of indi-
vidual cells were measured using Sigma Scan Pro (Systat Software, San Jose, CA), similar to our 
previous publication [138].  Cells with observable borders were analyzed manually.  Also, cells 
suspended in cell culture medium were evaluated.  For each condition, various numbers of cells 
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were analyzed.  Obtained parameters were exported to Microsoft Excel (Redmond, WA) for statis-
tical analysis.  First, mean, standard deviation, variance and standard errors were calculated for 
each condition to determine significant differences between groups.  Where the variance was ho-
mogenous, ANOVA analysis was used along with Tukey post hoc tests.  In conditions, where var-
iances were not homogenous, a Welch Test was performed along with Scheffé’s post hoc tests.  
4.2.4 Immunostaining  
To understand the effect of stimulation, samples were immunostained for neurite outgrowth (β-III 
tubulin), nuclei (DAPI), and actin (Alexa Phalloidin), using previous published protocols [139].  In 
brief, samples were fixed in 3.7% formalin for 30 minutes, washed 3 times with PBS, and perme-
abilized in 0.1% Triton X-100 in PBS for 30 min at room temperature.  Samples were blocked for 
60 minutes using 2.5% nonfat milk (prepared in PBS), incubated in mouse anti β-III tubulin in 
2.5% nonfat milk (1:500) for 60 minutes at room temperature, washed 3 times with Hepes Buffered 
Salt Solution (HBSS) for 5 minutes then incubated with goat anti mouse Alexa Fluor 488 (1:1000), 
DAPI (1:1000), and Alexa Fluor 546 Phalloidin (1:1000) in 2.5% nonfat milk.  Samples were rinsed 
3 times with HBSS for 5 min, prior to mounting the coverslip.  Florescent images were captured 
using Nikon Eclipse TE2000-U inverted microscope with attached CCD camera and Prior Scien-
tific Lumen 200 florescence illumination system, using Nikon UV, FITC, and TRITC filters.  
4.3 Results and Discussion 
4.3.1 A Compact Galvanotaxis Device 
While mechanical stimulation devices have been miniaturized for use in sterile conditions, there 
are no miniaturized devices to study galvanotaxis.  Currently available galvanotaxis devices have 
a custom made glass chamber for cell culture observation along with tubes filled with an agar so-
lution (typically 1-2%), [22, 24, 140]  and salt bridges connecting the electrodes, placed in glass 
beakers filled with isolated electrolytic solutions, and the cell culture chamber.  These devices are 
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cumbersome and require biosafety cabinets to maintain sterility for long term culture post-stimula-
tion.  I sought to develop a compact device that would allow us to expose cells to a constant EF 
without compromising either sterility, or prevent us from observing cells during exposure via light 
or fluorescent microscopy.  I coupled finite element analysis with 3D printing.  Three criteria used 
in designing a galvanotaxis device were: i) obtaining a constant EF so that all cells are subjected to 
the same stimulus; ii) isolating ionic products generated by the electrodes; and iii) increasing port-
ability while maintaining sterility.  With the low of cost custom-printing devices using 3D printing, 
one could consider making these devices disposable.   
Initial designs contained physical barriers to separate the cell culture chamber from electrodes.  
Since physical barriers are poor electrical conductors, holes were created to facilitate conductivity 
along the barrier.  As can be seen in Figure 4.4(a-c), non-uniformity in the voltage gradient and 
deformation of the EF lines (in black), caused by distortions of the EF near physical walls change 
the average EF across the chamber.  Further analysis of the electrical potential across the cell cham-
ber demonstrated this non-linearity (Figure 4.4h).  This is unlike a galvanotaxis device, reported 
in literature, which creates a uniform EF, with parallel EF lines (Figure 4.4g).  Nevertheless, I 
tested the prototype in Figure 4.4a and observed increases in resistance with time.  Resistive heat-
ing (electrical heating is proportional to resistance PI2R) caused agarose to dry at the positive 
electrode (Figure 4.3d).  I considered altering the conductivity of agarose surrounding the elec-
trodes.  Agarose gels have decreased conductivity with increased polymeric concentration [141].  
Although 2.0% (w/v) agarose is used for electrical stimulation of cardiac cells [140], this caused 
the run to end prematurely within 1 hour.  I tested 0.5% and 1% agarose and prepared them in 
phosphate buffered saline to improve conductivity.  With 0.5% agarose bubble formation near the 
electrode decreased and run time also extended.  I needed to minimize resistance throughout the 
device.  Since culture medium has essential electrolytes needed based on the extracellular fluid 
composition, there is little option in changing the conductive properties of cell culture medium.  
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However, the electric flux depends on the cross sectional area through which the current flows over 
cells.  Therefore, with a constant EF, decreasing the media height or width of the stimulator cham-
ber was an option.  I reduced the volume in the stimulator to 2mL.   
 
Figure 4.4:  Various design patterns for galvanotaxis. (a-c) compact devices incorporating 
physical walls and point electrodes (2mm) with different hole configurations: a) a single 3.81mm 
hole, b) a single 7.62mm hole, and c) three 5.00mm holes located at the center and 3.15in 
(8.00mm) to either side.  (d-f) A compact design without physical walls using disk electrodes lo-
cated: d) against the stimulator floor e) parallel at the same distance as the point electrodes, and f) 
with the electrodes located against the outer walls.  g) An example of a multicomponent galvano-
taxis device similar to those commonly found in literature [23].  Rainbow graphs are electrical 
potential, in volts. Black lines are electrical field lines, in black.  h) Changes in electrical potential 
(normalized to the maximum potential) across the cell culture chamber. 
 
I considered developing devices without physical walls and using disk electrodes to further mini-
mize resistance and spread the current over a larger area to reduce localized heating.  These changes 
decreased the overall electric potential required to maintain the desired EF in the cell culture cham-
ber, eliminated sharp changes in the voltage, and exhibited parallel EF lines (Figure 4.4d-f).  In 
addition, the electric potential gradient across the cell chamber was linear and the slope (i.e. the 
EF) was similar to the galvanotaxis device used in literature (Figure 4.4h):  since the input current 
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flux was calculated from the desired, constant EF, the electric potential gradient was constrained 
to a constant value in all designs.  The orientation of the disk electrodes did not affect the EF 
significantly.  I chose to place the electrodes at the ends of the chamber to i) increase path length 
of salt bridges, ii) fix the distance between electrodes, and iii) to ensure reproducible electrode 
placement.  When testing this prototype, agarose drying decreased significantly (Figure 4.3e), 
which improved run times to the required 3.5 hours.  I isolated the electrode leads from the system 
by passing them through holes in the ends of the devices and placing electrodes with silicone ad-
hesive.  I also created small wells between the agarose and electrodes which I filled with medium 
to allow generated gasses to escape.   
4.3.2 Galvanotaxis is Dependent upon Culture Duration 
Electrical field measurements in wound healing demonstrate endogenous electric fields, up to 200 
mV/mm.  Based on these results, some have applied electrical fields to in vivo conditions to pro-
mote wound healing [142].  Further, rat dorsal root ganglia have been shown to align vertically in 
a DC electric field[23].  I questioned how this would translate to in vitro cultures.  Unlike traditional 
galvanotaxis devices, my entire chamber fit inside a 100 mm petri dish wrapped with parafilm. The 
device was easy to transport and fit on the heated stage of an inverted microscope (Figure 4.3c).  
No contamination was observed 6 days after exposure when the coverslip was transferred to a 6-
well plate following experimentation.  
To test the influence of the compact device on cell orientation, I first stimulated NBs.  NBs re-
sponded to a 23.4 mV/mm EF (calculated from a 3mA direct current supplied to the stimulator).  
However, NBs showed little reaction to electrical stimulation after culturing for one (Figure 4.5a) 
or two days (data not shown):  there was no perceptible change in orientation or size of NBs over 
the 3.5 hr EF exposure period.  However, when cells were cultured for 6 days prior to stimulation, 
cell response was perceptible after 60-90 min of stimulation. Many NBs seeded directly (Control 
group) responded by changing their orientation (Figure 4.5b) and aligning vertically as compared 
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to the unstimulated control after 6 days of culture.  This result may indicate galvanotaxis in NBs is 
cell density dependent: cell-cell interactions may be required for NBs to detect and align to the EF.  
I quantified NB surface area, shape factor, major length and minor length to understand changes in 
cell phenotype.  These results showed (Figure 4.5c) a reduction in surface area with a constant 
shape factor.  After stimulation, cell surface area appeared to be similar to that of NBs suspended 
in cell culture medium.  This could suggest that applied current causes cell detachment.  However, 
comparison of the cell shape (Figure 4.5c) indicated a shape similar to that of adherent cells.  Fur-
ther, the major length of stimulated cells was significantly higher than suspended cells.  However, 
the minor length was significantly smaller than the adherent cells.  To better understand changes in 
cell thickness, I calculated cell volume from suspended cells using the equation of an ellipsoid and 
average minor length and major length values.  NB volume was 2650 (±727) m3.  Assuming NB 
volume remains constant (i.e., no change in osmotic pressure), I calculated cell thicknesses at var-
ious conditions using surface area.  Adherent NBs had 7.4 (±2.00) m thickness, significantly 
smaller than minor cell length in suspension.  After electrical stimulation, NB thickness increased 
to 13.4 (±3.45) m, which is still less than that of NBs in suspension.  This suggested that the NBs 
are not detaching from the surface but their thickness increases.  Nevertheless, I stained some sam-
ples with i) β-III-tubulin, an early intracellular marker indicating a neuron-like cell, ii) DAPI nu-
cleic stain, and iii) phalloidin, an actin stain.  Intracellular actin was observed in NBs, confirming 
cell attachment to the substrate after EF stimulation (Figure 4.5d).  Moreover, cells lacked β-III 
tubulin prior to stimulation but expressed diffuse β-III tubulin expression after 3.5 hr of stimulation.  
These results indicate that NBs respond similar to other neural cells subjected to an EF [23] and 
that the application of an EF might cause NBs to become more neuron-like without causing de-




Figure 4.5:  Effect of Stimulation and Culture Duration on NBs.  The left image of each pair 
is before stimulation and the right after stimulation.  NBs seeded onto coverslips and stimulated 
on a) day 1 and b) day 6. (c) Box and whisker plots showing the median, mean (thick line within 
the box), interquartile range box, and whiskers corresponding to 95 and 5 percentiles of area, 
shape factor, major length and minor length.  n value corresponds to number of data points in 
each condition.  Also, print condition corresponds to NBs printed through a 34g needle.  (d) Im-
munostained for B-III tubulin (green), DAPI (blue), and actin (red).  Scale bars are 100µm and 
current passes left to right (anode on left and on cathode right). 
 
Since NBs are cancerous progenitor cells, I wanted to understand the effect on a cell lineage that 
could be used in clinical setting.  For this purpose, I used hASC.  Based on NB experiments, I first 
performed stimulation experiments after six days of incubation.  I did not observe significant EF 
effect on hASC (Figure 4.6a).  Further, on day 6, there was no change in spread or orientation due 
to stimulation.  I questioned whether the long term culture could diminish sensitivity and stimulated 
the hASC after one day of incubation.  These results (Figure 4.6b) showed significant EF effects, 
unlike NBs on day 1, suggesting a culture duration dependent cell response to galvanotaxis.  Also, 
day one hASC responded within 15 min to EF, much faster than day 6 NBs, (60-90 min).  To 
understand changes in hASC phenotype, I quantified the surface area, shape factor, major length 
and minor length from day one cultures.  These results showed (Figure 4.6c) a reduction in surface 
area after EF stimulation while the shape remained the same; cell surface area reduced to nearly 
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that of cells in suspension in culture medium, similar to NBs.  However, comparison of the cell 
shape indicated a shape similar to that of adherent cells, unlike cells in suspension, which is nearly 
circular.  The reduction in cell area was primarily contributed by a significant reduction in major 
length, unlike NBs.  Minor axis also decreased marginally relative to adherent cells.  Similar to 
NBs, I calculated hASC volume when suspended.  The average hASC volume was 21900 (±11000) 
m3, nearly 8.26 times larger than NB volume.  Next, I calculated cell thickness when attached and 
after electrical stimulation using respective surface areas.  These results showed that the adherent 
cells had 6.8 (±3.27) m thickness, which is significantly smaller than minor cell length in suspen-
sion.  With the electrical stimulation, cell thickness varied significantly in the population 35(±36.2) 
m.  NB and hASC shapes are significantly different based on Tukey post hoc test with p<0.01.  
Since the variances of cell area, major length and minor length between NB and hASC were non-
homogenous, I performed Schiff tests.  These analyses confirmed that there are significantly dif-
ferent with p<0.01.   
 
Figure 4.6:  Effect of Stimulation and Culture Duration on hASCs.  The left image of each 
pair is before stimulation and the right after the end of stimulation.  hASCs seeded onto co-
verslips and stimulated on (a) day 2 and (b) day 6. (c) Box and whiskers plots showing the me-
dian, mean (thick line within the box), interquartile range box, and whiskers corresponding to 95 
and 5 percentiles of area, shape factor, major length and minor length.  n value corresponds to 
number of data points in each condition.  (d) Day 1 cultures immunostained for B-III tubulin 
(green), DAPI (blue), and actin (red).  Scale bars are 100µm and current passes left to right (an-




I stained some samples with β-III-tubulin, DAPI, and phalloidin as before.  Immunostained hASCs 
on day one, showed some diffuse expression of β-III tubulin without a loss of filamentous actin, 
immediately after the 3.5 hr exposure to EF, similar to NB response on day 6 (Figure 4.6d).  This 
indicates that hASCs may be differentiating toward a neural lineage and change in cellular shape 
does not indicate a loss of attachment, supporting my conclusion that cells are not detaching due to 
EF exposure. 
4.4 Discussion 
My galvanotaxis device demonstrates how 3D printing technologies can be leveraged by research-
ers within the tissue engineering community to create devices that overcome the drawbacks of tra-
ditional laboratory setups.  Moreover, these devices are inexpensive to produce.  In addition, I 
utilized one model per design, which was imported into COMSOL for simulation and then directly 
printed using a 3D printer.  Therefore, the entire design phase was conducted using a single model: 
I simulated the EF, rapidly printed and tested prototypes, refined my design via additional simula-
tions and printing of prototypes and then printed multiple ‘production’ units.  This approach could 
be applied to numerous devices used by tissue engineering researchers to replace cumbersome set-
ups assembled from readily available laboratory materials and designs can be shared digitally be-
tween researchers, allowing custom devices to rapidly spread preventing other laboratories from 
conducting unnecessary design work.   
I found a surprising dependence of cell function on culture time.  Cell culture experiments tend to 
be conducted approximately 24 hr after seeding, if the culture time is reported at all.  As mentioned 
previously, this difference is easily observed when exposing cells to EFs, however the dependence 
would be much less clear when exposing cells to chemical signals.  Therefore, culture duration may 
also play a significant role in ADSC differentiation.  I find a strong time-dependent difference in 
cell response with culture time post seeding, independent of passage number.  In addition, I ob-
served a distinctly different effect of culture time on the two cell types investigated.  I cannot state 
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whether this is necessarily a concentration based or purely time-dependent phenomena.  It is pos-
sible that galvanotaxis is dependent upon the growth phase in which the cell lines are found.  How-
ever, NB carcinoma respond to an EF after 6 days, while ADSCs respond on day 2.  NB do not 
respond noticeably to EF on day 2, and ADSCs do not respond noticeably on day 6.  In addition, 
NB are not confluent on day 6, reducing the likelihood that the cellular response I are observing is 
due to a change in the growth regime.  
It was interesting that I observed a lack of response from ADSCs with increased culture time and 
at a higher cell density.  My micrographs did not show visual confluency, so I do not expect that 
contact inhibition is an issue.  Moreover, it is known that the stem cell pool has increased cell 
number later in life with decreased functionality.  I hypothesize that stem cell concentration may 
play an important role in the population’s ability to differentiate.   
While the evidence presented in this work suggests that culture time is important when considering 
cell responses, additional work may lead to a clearer understanding of what cells are experiencing.  
First, trypsin is well known to damage CAMs.  Therefore, investigating the galvanotactic response 
of cells cultured on poly-NIPAM treated cell culture dishes to eliminate trypsin may be of interest.  
Poly-NIPAM is a thermally responsive polymer that has been shown to cause cell detachment when 
the temperature is lowered from 37°C to room temperature [143].  Use of this polymer coated cell 
culture dish is expected to prevent CAM damage from trypsin and will ensure that the responses I 
observe are not caused by trypsinization.  Second, use of neural culture medium, instead of contin-
uing to culture cells in hASC medium, might be expected to increase the number of cells that ex-
press β-III-tubulin. 
4.5 Conclusions 
In this work, I successfully developed a compact stimulator with uniform electrical field using 
computational simulation to obtain a uniform electrical field and 3D printed devices of interest.  I 
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tested these devices on NB and hASC. I observed that NB and HADSCs respond to EFs with vastly 
different culture times.  I demonstrated that β-III-tubulin expression and galvanotactic response is 
affected by the time in culture.  Overall, I demonstrate that culture time is important when consid-
ering cell responses, and that the observed effect is not a function of increasing concentration for 
NB, which may be true for stem cell differentiation as well.  My findings may tie in with others 
that the stem cell pool increases in population with age while their utility decreases and indicates 







BIOPRINTING CHANGES CELL MORPHOLOGY, EXPRESSION, AND RESPONSE 
TO AN ELECTRICAL FIELD 
 
5.1 Introduction 
Despite their acceptance by the medical community and use in clinical settings, premade scaffolds 
are difficult to shape into complex geometries and require random cell seeding—preventing control 
of the arrangement and distribution of different cell types.  While some cell types may self-assem-
ble into the proper spatial relation, this process does not always occur and is usually lengthy.  Bi-
oprinting provides a viable solution:  it allows spatial location of multiple cell types in relation to 
one another and the creation of complex, multicellular tissue analogs and reduces reliance on cell 
self-assembly.  However, bioprinting processes often damage cells, decreasing their viability and 
possibly altering cell functionality.  There is limited understanding of the effects of crosslinking 
mechanisms on cell processes post-printing.   
In this work, I investigated and compared the effect of bioprinting on neuroblasts (NBs) and human 
adipocyte stem cells (hASCs) in both cell culture medium and chitosan-gelatin (CG) hydrogel ex-
plored in Chapter 3.  In order to test the effect of bioprinting, I used the compact galvanotaxis 
device, developed in Chapter 4.  These results show that some human adipocyte stem cells differ-
entiate towards neuron-like cells after bioprinting and culturing up to 6-days.  
72 
 
5.2 Materials and Methods 
5.2.1 Materials 
Low molecular weight chitosan (50 kDa and 75-85% deacetylation), gelatin (300 bloom, Type A, 
from porcine skin), and agarose powder were purchased from Sigma Aldrich Chemical (St. Louis, 
MO). β-glycerophosphate was purchased from Santa Cruz Biotechnology, Dallas TX.  IMR-32 
Neuroblasts, Eagle’s minimum essential medium (EMEM), Fetal Bovine Serum, and 0.05% Tryp-
sin-EDTA were purchased from The American Type Culture Collection (ATCC – Manassas, VA).  
StemPro Human Adipose-Derived Stem Cells, MesenPRO RS Medium, MesenPRO RS Growth 
Supplement, L-glutamine, Dulbecco's phosphate-buffered saline (DPBS), TrypLE Express, Car-
boxyfluorescein diacetate succinimidyl ester (CFDA), Live/Dead Cell Vitality Assay Kit (C12 
Resazurin/SYTOX), Alexa Fluor 488 goat-anti-mouse IgG2a antibodies (A-21131), 4',6-Dia-
midino-2-Phenylindole, Dihydrochloride (DAPI), and Alexa Fluor 546 Phalloidin were purchased 
from ThermoFisher Scientific (Waltham, MA).  TUJ1 clone anti-β-III tubulin mouse primary 
IgG2a antibodies were purchased from Biolegend (801201; San Diego, CA).  Ag/AgCl point elec-
trodes were purchased from In Vivo Metrics (Healdsburg, CA).  Ag/AgCl disk electrodes (9mm 
diameter and 1mm thick) were purchased from ALA Scientific Instruments (Farmingdale, NY).  
Polylactic acid (PLA) printer filament was obtained from MakerBot (New York City, NY).  Sili-
cone adhesive was obtained from Lowes (Stillwater, OK).  
5.2.2 Evaluating Galvanotaxis of Bioprinted Neuroblasts and Adipose Derived Stem Cells 
IMR-32 neuroblasts (CCL-127) and StemPro human Adipocyte Stem Cells were cultured accord-
ing to the manufacturers’ protocols.  Briefly, NBs were cultured in EMEM with 10% FBS.  Medium 
was changed three times per week.  hASCs were cultured in MesenPRO RS medium with 10% 
Growth supplement and 2mM L-glutamine.  Medium was changed every 3-4 days.  Both cell types 
were incubated in a humidified chamber at 37°C, 5% CO2, 95% air.  When confluent, NBs were 
suspended using 0.5% trypsin-EDTA, centrifuged at 125×g for 5 minutes, and re-suspended in 
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fresh medium.  When confluent, hASCs were rinsed with Dulbecco’s Phosphate Buffered Saline, 
and suspended in pre-warmed TrypLE Express.  Viable cells were counted using a hemocytometer 
and trypan blue.  hASCs were used at passage 3.  18mm square microscope coverslips were coated 
with 0.1% gelatin, and air dried in a biosafety cabinet.  After drying, each cover slip was placed in 
a 6-well plate.  Both hASCs and NBs at 22.2×103 cells were added on to the coverslips in two 
different ways and incubated until further analysis 
(i)  Printed using cell culture medium:  Cells suspended in cell culture medium (2×106 cells/mL) 
were printed directly on to the slides using a 34-g (60-m nozzle diameter) or 32-g (102-m nozzle 
diameter) needles.  All bioprinting was done at the optimized condition described in Chapter 3: 30 
L/min flow rate and at a feed rate of 100cm/min using my custom-built bioprinter . 
(ii)  Printed using CG hydrogel solution: Cells were mixed with CG thermosensitive solution as 
described in the next section, and printed at conditions similar to the cell culture medium. 
Printed constructs with cells were placed in an incubator for one hour, prior to adding 2mL of 
culture medium.  On day 2 or 6 after seeding, a coverslip was transferred into a prepared galvano-
taxis device using sterile forceps, and the device was placed into a sterile petri dish and wrapped 
with parafilm.  The stage ring of a Nikon Eclipse TE2000-U inverted microscope was replaced 
with a Nikon Thermo Plate, which was maintained at 37 C.  The galvanotaxis device was placed 
on the thermo plate and cells were continuously monitored using the attached CCD camera (Figure 
2c).  For stimulation, 3 mA direct current was applied using a PowerEase® 500 Power Supply 
(Invitrogen, Carlsbad, CA).  Digital micrographs were acquired at 15 min intervals.  Cells stained 
with the non-toxic, cytoplasmic stain CFDA-SE were observed with the florescence illumination 
system.  Stimulation periods were chosen based upon control cellular response.  To avoid photo-
bleaching, fluorescent images were acquired prior to stimulation, at 90min, and at the end of the 
stimulation.  Some cultures without pre-stained cells were evaluated via immunostaining using both 
fluorescent microscopy and flow cytometry.   
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5.2.3 Printing Cells using CG hydrogel solution 
3%-3%, 2%-8%, and 1%-8% chitosan-gelatin solutions (%chitosan-%gelatin, w/V) were prepared 
in deionized water, similar to Chapter 3.  Briefly, the solutions were sterilized using dry heat at 
120°C for 30 minutes in tightly sealed bottles.  Then, 200µL of hydrochloric acid (37%) was added, 
per gram chitosan, in a sterile hood. The prepared mixture was stirred on a heated stir plate over-
night at 58°C.  Immediately prior to use, the solution was centrifuged and the supernatant trans-
ferred to a new tube to remove particulates. Then β-glycerophosphate was slowly added to the 
solution until it reached a pH of 7.20-7.40 and centrifuged again to remove bubbles.  Then cells 
were added and the cell-hydrogel mixture was printed using my bioprinter, as described previously 
[144]: Cells were stained with 2-4 µM CFDA-SE in phosphate buffered saline (PBS), washed with 
PBS, mixed into prepared hydrogel at a concentration of 2×106 cells/mL, loaded into a 1-mL sy-
ringe and printed using either a 34-g or a 32-g needle.  Since the intent was to test the effect of 
printing and then electrical stimulation, 1.8cm long fibers were printed in parallel with 2.0 mm 
spacing between them onto gelatin-coated coverslips placed inside 6-well plates.  After printing, 
the plates were placed in an incubator for one hour to allow for gelation to complete, 2 mL of 
culture medium were added, and the plates were returned to incubation and routine culture until 
further analysis one or six days later. 
5.2.4 Electrical Properties of Hydrogel and Cell Culture Medium 
The electrical properties of hydrogel formulations and cell culture medium were measured using a 
Hach SensION5 (Loveland, CO).  Hydrogel was mixed and transferred into the measurement cham-
ber of the device’s probe, wrapped in parafilm, and incubated at 37°C for 30 min to allow the 
hydrogel to gel.  After the 30 min incubation, the parafilm was removed and the probe was placed 
in a 50 mL centrifuge tube with 20 mL of cell culture medium and equilibrated for 30 min before 
recording the conductivity value.  Measurements were taken for three preparations of 1%-8%, 2%-
8%, and 3%-3% hydrogel each.  The average and standard deviation were calculated.  Medium 
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electrical properties were measured by placing the probe into 20mL of medium pre-warmed to 
37°C and immediately taking the measurement.  
5.2.5 Immunostaining for Microscopy and Flow Cytometry and Viability Analysis 
To understand the effect of stimulation or bioprinting, samples were immunostained for neurite 
outgrowth (β-III tubulin), nuclei (DAPI), and actin (Alexa Phalloidin), using previous published 
protocols [139].  In brief, samples were fixed in 3.7% formalin for 30 minutes, washed 3 times with 
PBS, and permeabilized in 0.1% Triton X-100 in PBS for 30 min at room temperature.  Samples 
were blocked for 60 minutes using 2.5% nonfat milk (prepared in PBS), incubated in mouse anti 
β-III tubulin in 2.5% nonfat milk (1:500) for 60 minutes at room temperature, washed 3 times with 
Hepes Buffered Salt Solution (HBSS) for 5 minutes then incubated with goat anti mouse Alexa 
Fluor 488 (1:1000), DAPI (1:1000), and Alexa Fluor 546 Phalloidin (1:1000) in 2.5% nonfat milk.  
Samples were rinsed 3 times with HBSS for 5 min, prior to mounting the coverslip.  Florescent 
images were captured using Nikon Eclipse TE2000-U inverted microscope with attached CCD 
camera and Prior Scientific Lumen 200 florescence illumination system, using Nikon UV, FITC, 
and TRITC filters. 
Some samples were immunostained as described above, except cells were detached from the sur-
face, then fixed and stained in suspension for flow cytometry (FACSFlow, BD Biosciences).  
Cells were stained at 4°C.  
hASCs were printed using culture medium through a 32g needle followed by a 5-day incubation 
for viability analysis, similar to that used previously for NB viability [144].  Non-printed hASCs 
were used as controls.  On day 5, the cells were stained with the C12 Resazurin/SYTOX live/dead 
assay kit according to the manufacturer’s protocol and our previous work [144].  Briefly, cells were 
washed with DPBS then detached from tissue culture plastic using TrypLE express.  Then hASCs 
were spun down at 210xg for 5 min and re-suspended in 100µL of PBS with 500nM C12 Resazurin 
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and 20nM STYOX green and incubated for 15 minutes.  After incubation, hASCs were placed on 
ice and immediately analyzed by flow cytometry.   
5.3 Results and Discussion 
5.3.1 Bioprinting Affects Cellular Morphology and Expression Differently. 
To understand the effect of shear stress during bioprinting on cell function, NBs suspended in cul-
ture medium were printed using 34g (60 m internal diameter) and 32 g needle (120m internal 
diameter).  In Chapter 3, I reported that NBs printed through a 34g needle, in culture medium, 
maintain high cell viability, similar to that of unprinted NBs.  To extend those analyses, I compared 
cell phenotypic characteristics.  Interestingly, without stimulation, more NBs appeared to be 
aligned when printed through a 34g needle (Figure 5.1b) relative to printing through a 32 g needle 
(Figure 5.1c) or non-printed samples (Figure 5.2a).  To understand the difference in shear stress 
experienced by the cells, I used the viscosity of water at 25 C and the 30 L/min flow rate used 
during bioprinting to calculate shear stresses for laminar conditions (the Reynolds number was 
approximately 15).  In 34-g needles, the wall shear stress was 26.3 N/m2.  These values decreased 
by 8.7 fold in 32-g needles, where the wall shear stress was 3.01 N/m2.  Thus, the higher shear 
stress may assist cell alignment.  In any case, bioprinting increased NB surface area (Figure 5.1g) 
significantly relative to stimulated or unstimulated cells.  However, cell shape increased towards 
suspended cells.  This increase in circularity was mainly due to increased minor length, which 
resulted in decreased cell thickness to 4.4 (±1.83) m.  Based on NB response to EF stimulation 
after a 6-day incubation in directly seeded cells (Figure 5.1a), I stimulated printed NBs 6 days 
post-printing (Figure 5.1b and c).  EF stimulation had an opposite effect on NB morphology com-
pared to stimulation of non-printed cells (Figure 5.2g).  Bioprinted cells showed similar or mar-
ginal improvement in cell spreading area, which was due to increased minor length but almost no 
change in shape factor or major length.  Overall, cell thickness reduced to 3.4 (±0.91) m, which 
is significantly smaller than that of stimulated, non-printed NBs.   
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I questioned how bioprinting could affect a cell type that is more relevant to many synthetic tissue 
applications.  Therefore, I printed hASCs, suspended in culture medium, using a 32g and a 34g 
needle.  Before analyzing phenotypic changes, I performed cell viability analysis, similar to that 
performed on NBs (i.e., after five days of printing in cell culture medium using a live/dead assay) 
to ensure that the printing process was not causing cell death.  Flow cytometry demonstrated that 
hASC viability was nearly 81% after printing, compared to a control viability of 88%.  Moreover, 
the injured cell population was 16% for bioprinted cells, compared to 11% for controls.  After 
confirming high viability, similar to my observations of NBs, I compared hASC phenotypic char-
acteristics.  Interestingly, bioprinting using a 34g needle (Figure 5.1e) or a 32 g needle (Figure 
5.1f) increased hASC surface area significantly, relative to non-printed hASCs (Figure 5.1d), irre-
spective of stimulation (Figure 5.1h).  However, hASC shape showed significant elongation con-
comitant with an increase in major length (Figure 5.1e and f).  In particular, many cells printed 




Figure 5.1:  Effect of bioprinting in medium and electrical stimulation on cell morphology. The 
left image of each pair is before stimulation and the right after stimulation. Unprinted NBs (a), 
NBs printed through a 34g (b) and 32g (c) needle.  All NBs were stimulated on day 6. Unprinted 
hASCs (d), hASCs printed through a 34g (e) and 32g (f) needle. All hASCs were stimulated on 
day 1. Scale bars are 100µm and current passes left to right (anode on left and cathode on right).  
Box and whisker plots for (g) NB and (h) hASCs showing the median, mean (thick line within the 
box), interquartile range box, and whiskers corresponding to 95 and 5 percentiles of area, shape 
factor, major length and minor length.  n value corresponds to number of data points in each con-
dition.  Also, for (g), print condition corresponds to NBs printed through a 34g needle 
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appearance, which reduced the shape factor (Figure 5.1e).  These variations contributed to the 
broader distribution of cell morphologies.  These effects are opposite to those observed when stim-
ulating NBs (Figure 5.2g), despite hASCs’ significantly greater cell volume compared to NBs 
(~8.26 times greater).  Nevertheless, increased area resulted in decreased cell thickness to 4.4 
(±3.66) m. Based on hASC response to EF stimulation after a  one day incubation in directly 
seeded cells (Figure 4.1d), printed hASCs were stimulated one day post-printing through either a 
34g (Figure 5.1e) or 32g (Figure 5.1f) needle.  Unlike NBs, I observed a response similar to non-
printed hASCs (Figure 5.1h).  Bioprinted hASCs showed similar reduction in cell spreading area 
compared to non-printed hASCs (Figure 5.1h), which was due to reduced major length.  Cell shape 
appeared to be similar to that of control cells.  Overall, cell thickness did not change.   
In addition to morphological evaluation, both NBs and hASCs were evaluated for β-III-tubulin 
expression (green), for polymerized actin (red), with cells located by nucleic DAPI staining (blue).  
When printed through a 34g needle, NB polymerized actin expression appeared to be decreased 
(Figure 5.2d) relative to NBs printed through a 32 g needle (Figure 5.1c) or non-printed NBs 
(Figure 5.2a).  Concurrently, when stimulated, NBs that had been printed through a 34g needle did 
not express β-III-tubulin or polymerized actin (Figure 5.2 d).  However, when NBs that had been 
printed through a 32g needle were stimulated, β-III-tubulin expression and polymerized actin were 
both expressed, although clearly to a lesser degree than in non-printed samples (Figure 5.2a).  The 
partial recovery of expression in NBs printed through a 32g needle suggests that there could be a 
limit to the level of shear stress that NBs can tolerate.  Because of hASCs greater volume, I printed 
hASCs through a 32g needle.  Interestingly, I found that hASCs printed through a 32g needle ex-
hibited no change in polymerized actin (Figure 5.2f), compared to non-printed hASCs (Figure 
5.2c).  However, unlike non-printed hASCs, hASCs printed through a 32g needle expressed β-III-




Figure 5.2:  Immunocytometry of Printed and Non-Printed Cells.  Cells were immunostained 
for B-III tubulin (green), DAPI (blue), and actin (red).  The left image of each pair is before stim-
ulation and the right after stimulation. Scale bars are 100µm and current passes left to right (an-
ode on left and on cathode right).  Unprinted NBs (a) compared to NBs printed through 32g (c) 
and 34g (d) needle.  All NBs were stimulated on day 6 and stained immediately after stimulation. 
Non-stimulated NBs were stained concurrent with stimulated samples. Unprinted hASCs (e) com-
pared to hASCs printed through a (32g) needle.  All hASCs were stimulated one day after seeding 
and stained immediately after stimulation.  Non-stimulated NBs were stained concurrent with 
stimulated samples. 
 
To better understand potential cell differentiation in hASCs, I extended culture to 6 days after bi-
oprinting or 6 days after stimulation.  When printed through either a 32g needle (Figure 5.3a) or a 
34g needle (Figure 5.3b), some hASCs exhibited β-III-tubulin across the entire cell surface.  In 
hASC printed through a 34g needle and not stimulated, axonal-like structures containing increased 
expression of β-III-tubulin, with a very small cytoplasmic region appeared (Figure 5.3b, left).  This 
suggests a short exposure to shear rate may be causing stem cell differentiation towards a neuronal 
phenotype. Interestingly, when EF stimulated cells were cultured for 6-days, many cells showed 
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increased expression of β-III-tubulin in both 32g and 34g needle printed conditions (Figure 5.3a, 
r, right).  In addition, there were many axon-like structures in both conditions.  This suggests that 
EF may influence stem cells to differentiate and that hASC may be subject to greater deformation 
than NB due to increased cell size.  hASCs’ relatively greater volume requires more of the needle 
cross section than NBs’ volume and subjects them to higher shear stress nearer to the wall.  Re-
cently, higher shear stresses and shear rates, similar to those in a 34g needle, have been reported in 
bone marrow [145].  These results suggest that the shear rate could play a role in differentiation 
rather than shear stress.  In all cases, there were hASC with abundant actin fibers and without β-
III-tubulin expression.  One has to evaluate whether non-β-III-tubulin expressing cells are non-
differentiated, are muscle cells, or are other lineages.  Also, cell wall pliability could decrease with 
lineage commitment.  Showing that the β-III-tubulin cells behave similar to that of neurons would 
be valuable to confirm differentiation.  Also, I cultured hASC in the same culture medium used for 
their propagation without differentiation i.e., there was no chemical stimulus added to the culture 
medium.  Many have explored differentiating stem cells using various chemical stimulus.  I need 
to test whether culturing hASCs in a lineage specific culture medium would promote faster and 




Figure 5.3:  Immunocytometery of hASCs Cultured an Additional 6-Days.  immunostained 
hASCs with B-III tubulin (green), DAPI (blue), and actin (red).  The left image of each pair is be-
fore stimulation and the right after stimulation. Scale bars are 100µm and current passes left to 
right (anode on left and on cathode right). hASCs printed through a 32g needle (a, left) or 34g 
needle (b, left) then cultured for 6 days before staining. hASCs printed through a 32g needle (a, 
right) or 34g needle (b, right), stimulated one day after printing, then cultured for 6 days before 
staining.   
 
5.3.2 Bioprinting Cell Laden Structures with Thermosensitive Gels Affects Cell Spreading  
Bioprinting cell laden structures allows precise placement of cells and matrix elements in a desired 
location.  During 3D bioink development, the focus has been the rapid gelation of fibers to obtain 
higher resolutions.  In Chapter 3, I showed that chitosan-gelatin (CG) -glycerophosphate (2GP) 
hydrogels are suitable inks for printing cell-laden structures.  CG-2GP solutions spontaneously 
form hydrogels at 37C without needing post-processing [146]; the solution (pH=7.4) remains in 
liquid phase at room temperature allowing the possibility of uniform mixture of cells.  It is non-
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immunogenic in a mouse-transdermal model [146], supports matrix synthesis by fibroblasts [78], 
and has tunable mechanical properties through alteration of chitosan and gelatin concentrations and 
by selectively cross-linking gelatin after gelation using transglutaminase (TG) [57].  NBs were 
printed as vertical lines perpendicular to the application of EF after suspending in 3%-3% CG so-
lution on a 37 C stage and allowed to gel.  Formed fibers are porous, probably due to the leaching 
of -glycerophosphate.  One could observe formed 3%-3% hydrogels with 160 m fibers within 
which cells were dispersed (Figure 5.4a-b), similar to results in Chapter 3.  Although fibers were 
stable even after six days of culture post-printing, cells did not spread and appeared circular, similar 
to suspended cells.  In order to understand how NBs would respond to changes after bioprinting, I 
tested the effect of EF on printed structures.  These results showed no significant changes in cell 
morphology after EF stimulation either after one or six days of culture.  I thought that reduced 
spreading could be attributed to increased mechanical stiffness of the fibers and a reduced number 
of cell-binding domains.  To test this possibility, I printed cells using 2%-8% CG solution (Figure 
5.4c-d).  Reduction in chitosan concentration is known to decrease gelation rate; this increases 
solution spreading.  2%-8% fibers were larger than 3%-3% fibers, with a large number of cells in 
the field of view under the microscope.  I observed some cell spreading in 2%-8% CG hydrogel on 
day 6 (Figure 5.4d).  Previously I have observed cell spreading on the surface of CG hydrogels 
and alignment with applied hydrodynamic shear.  Nevertheless, application of EF stimulation did 
not alter the cellular morphology of cells encapsulated in the CG hydrogel.  This indicated more 





Figure 5.4:  Effect of encapsulating in the hydrogel on NB morphology.  Cells were pre-
stained with non-toxic cytoplasmic stain CFDA-SE for identification within the fiber.  The left 
image of each pair is before stimulation and the right after the end of stimulation.  NB printed in 
3%-3% CG hydrogel and stimulated on a) day 2 and b day 6, and NB printed in 3%-3% CG hy-
drogel and stimulated on c) day 2 and d) day 6. Scale bars are 100µm and current passes left to 
right (anode on left and on cathode right). (e) Change in conductivity for different CG formula-
tions.  Increasing concentrations of negatively charged chitosan change the conductivity of chi-
tosan-gelatin hydrogels, while gelatin concentration does not.  Data is shown as average with er-
ror bars equal to 1 standard deviation (n=3). 
 
Since no effects were observed after EF stimulation, I questioned whether the conductive properties 
of the CG ink could affect the EF experienced by cells.  I measured the conductivity for 1%-8%, 
2%-8%, and 3%-3% CG hydrogels.  A linear increase in conductivity with increased chitosan con-
centration was observed irrespective of gelatin concentration (Figure 5.4e).  All concentrations of 
the CG hydrogels were at least 1 S/m more conductive than cell culture medium (Figure 5.4e).  
Hence, CG hydrogels are not isolating cells from the EF during exposure.  These fibers are also 
very thin, and hence changes in EF should be negligible.  In any case, the effect of altering the 
bioink formulation should to be tested.  Laminin has been used to promote neuronal differentiation.  
Therefore, adding laminin to the hydrogel might demonstrate improved differentiation. 
5.4 Discussion 
In this work, I bioprinted neuroblasts and human adipocyte stem cells (hASC) using my custom-
built bioprinter, described in Chapter 3.  I printed both cells using 34g needle (60 m internal 
diameter) and 32g needle (120 m internal diameter) using culture medium and CG thermosensi-
tive hydrogel described in Chapter 3.  I cultured these cells up to six days and show that printed 
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hASC differentiation towards neurons using immunohistochemistry for -III tubulin and actin.  
These cells are viable and there was a progressive increase in -III tubulin expression.  Printing 
hASC using 34g needle had more effect than 32g needle, which is remarkable given the cell size 
of hASC (32 to 38m in diameter when suspended in culture medium) and short exposure time to 
such stress.  Phenotypic changes corroborate such effects.  I demonstrate that β-III-tubulin expres-
sion and galvanotactic response are affected by bioprinting.  However, further studies are required 
to understand the functionality of differentiate stem cells via measurement of membrane potentials 
and the efficiency of differentiation.  Needle diameter could be an important factor in cell differ-
entiation caused by bioprinting.  As new bioink formulations are explored, it might be possible to 
leverage bioprinting to differentiate cells in complex, printed architectures.  However, it will be 
important to consider the nature of the inks used and post-processing effects. 
I initially expected that, because there was very high cell viability, the lack of NB spreading and 
galvanotactic response after printing in hydrogels was a consequence of hydrogel stiffness. Sup-
porting this hypothesis, I observed cell spreading with decreased chitosan concentration. However, 
I did not observe a galvanotactic response from NBs printed in hydrogel, which indicates that al-
tered cell response caused by stresses imparted by the printing process likely impacts cell spread-
ing, and may even be the dominant cause of the lack of galvanotaxis, not the hydrogel properties.  
However, exploring the hydrogel’s osmolarity is also of interest: while the pH of the solution is 
adjusted to 7.4, which is physiologically normal, the concentration of glycerophosphate salt in the 
hydrogel may create a hyperosmotic environment.  This may also contribute to or cause a lack of 
cell spreading and response due to transport of water from the cell to the hydrogel. 
There is increasing interest in the use of small scale, pseudo organs for pharmacological, cancer, 
and functional models using bioprinting.  I observe greater changes in cellular response, specifi-
cally the presence of polymerized actin, in NBs than hASCs.  This indicates that post-printing 
functionality should be evaluated for specific cell types and applications.  Moreover, contrary to 
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conventional wisdom, stem cells may not be the most sensitive and easily affected cell type.  Con-
sidering the sensitivity of carcinoma cell lines may be important for tumor and other cancel models.  
This could be because time is required for cells to re-develop focal adhesions and polymerized actin 
filaments, possibly due to damage to integrins and other CAMs.  It might also be because galvano-
taxis in NBs is cell concentration dependent:  cell-cell interactions may be required for NBs to 
detect and align to an applied EF. 
5.5 Conclusions 
Bioprinting research currently focuses on reducing negative impacts of the printing process on cell 
survival, without considering cell response as a separate evaluation criterion.  In the context of my 
optimization of printing process in chapter 3, my results demonstrate that unwanted cell alterations 
(i.e. loss of response and changes expression) can be imposed upon cells by the bioprinting process, 
despite high cell viability.  Unlike non-printed NBs, after printing in media through a 34g needle, 
NBs did not demonstrate polymerized actin.  Nor did they express β-III-tubulin after stimulation.  
Moreover, while printing in media through a 32g needle demonstrated some polymerized actin and 
β-III-tubulin expression after printing, it appeared that expression was lower than unprinted cells.  
Interestingly, printing did not affect hASC actin polymerization.  However, printing alone caused 
some hASCs to express β-III-tubulin.  Based upon evidence from extended hASC culture, the print-
ing process caused β-III-tubulin expression, which did not appear to increase with stimulation.  
When printed in 2%-8% CG hydrogel, cells spread very little and do not exhibit galvanotaxis.  The 
lack of spreading and galvanotaxis may be due, in part, to shear based effects on cells.  However, 






CONCLUSIONS AND RECOMMENDATIAONS 
6.1 Conclusions 
Bioprinting research has focused on the printability of new hydrogel-based inks, exploring the 
quality of 3D structures that can be produced and ensuring the processing parameters required do 
not adversely affect cell viability.  However, there is very limited understanding of how bioprinting 
alters cell response; some assume that high viability infers normal function and unaltered stimulus 
response.  Moreover, most inks require post-processing steps to stabilize the ink that may damage 
cells or alter their function.  This work demonstrates a hydrogel that does not require post-pro-
cessing and indicates that high viability does not imply unaltered stimulus response.  
My work focused on bioprinting three dimensional structures from a novel chitosan-gelatin hydro-
gel with an unique gelation characteristic amongst explored inks, and evaluating bioprinting effects 
on electrical cell responses using a compact electrical stimulation device.  The work was grouped 
into three aims:  In aim 1 (Chapter III), I introduced a bioprinter ink and provided insight into the 
challenges and advantages of printing with an ink that has irreversible gelation with increasing 
temperature, neither which have been explored previously.  In aim 2 (Chapter IV), I detailed the 
design of a compact electrical stimulation device which retains the structure of traditional stimula-
tors while allowing sterile observation during stimulation, validated the responses of NBs in the 
context of work conducted in literature and further explored NB and hASC responses to a DC 
electrical signal and their changes in expression.  In aim 3 (Chapter V), I explored how bioprinting
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affected NB and hASC responses to electrical stimulation and, changes in expression of β-III-tu-
bulin indicating differentiation towards a neural lineage.  
6.1.1 Aim 1: Create a Bioprinting Process for Chitosan-Gelatin-β-glycerophosphate Thermogel-
ling Hydrogel 
In Chapter III, I described the printability of the chitosan-gelatin-β-glycerophosphate hydrogel and 
the effect of printing on cell viability.  I developed a process to print the hydrogel using a low cost 
(<$800), compact 3D printer:  I designed an extruder to use disposable syringes and hypodermic 
needles to print the hydrogel and utilized petri dishes with level cooled agarose print surfaces to 
overcome petri dish floor variation and maintain a constant gap with the needle tip.  Further, I found 
that degassing and precooling the solution were necessary preparation steps to obtain continuous 
fibers.  I found that the print surface temperature varied by up to 33°C compared to the heated plate 
and that the temperature profile was more constant across an agarose surface than water.  While 
investigating fiber size parameters, I found that flow rates between 5 µL/min and 60 µL/min did 
not affect the fiber size.  Fiber size decreased from 760µm, to 243µm as the feed rate increased 
from 10cm/min to 100cm/min with greater changes in fiber size at 25°C than 37°C.  Increased 
needle height initially decreased fiber size but then increased showing an optimum.  Overall, bed 
temperature played the greatest role in fiber size followed by feed rate.  Structures approximately 
1mm high were printed using 13 layers of hydrogel.  Finally, cells were uniformly distributed 
within the fibers and exhibited high viability and no contamination after 5 days [23].  
6.1.2 Aim 2: Develop a compact electric stimulation device and test the response of neuroblasts 
and human adipocyte stem cells  
In chapter IV, I described the development of a compact electrical stimulation device that could be 
used to understand cell responses to electric fields after bioprinting.  A compact device was devel-
oped that matches the footprint of a standard microscope slide and produces a uniform electric 
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field, similar to traditional electrical stimulation devices, was easy to transport, and could be ob-
served via light microscopy during stimulation while maintaining sterility.  Open devices with disk 
electrodes had less variation in EF and ran longer than devices with physical walls and point elec-
trodes.  Vertical NB alignment, similar to results obtained for other neural cells, was observed after 
six days of culture but not after one day.  The electrical field effect was also evaluated on hASCs, 
which showed a decrease in cell area on day 1 but not day 6, indicating culture time affects cell 
response differentially by cell type.  Further, I immunostained NBs and hASCs before and after 
stimulation for β-III-tubulin an early neural marker, for the cell nucleus (DAPI), and for actin (Phal-
loidin).  I observed β-III-tubulin expression in both NBs and hASCs after stimulation.  In summary, 
a compact device was developed to observe cells during electrical stimulation without sacrificing 
sterility and maintaining similarity to traditional devices.  Further, the responses of NBs and hASCs 
demonstrate cells respond to stimulation differently based upon culture time and that electrical 
stimulation may differentiate both hASCs and NBs towards a neural lineage.  
6.1.3 Aim 3: Evaluate the effect of bioprinting and electrical stimulation separately and jointly on 
NBs and hASCs  
Described in chapter V, this aim sought to evaluate the combined and separate effect of bioprinting 
and electrical stimulation on NBs and hASCs.  I demonstrated that the printing process alters cell 
morphology and response when printed in medium and hydrogel.  When printed in medium, 
through a 34g needle, NBs had a shape factor closer to one with a correspondingly larger minor 
length, although they did not appear to be detaching because the cell height decreased.  NBs did 
not respond to electrical stimulation; they had no significant change in any of the measured shape 
parameters compared to printing alone. However, when printed through a 32g needle, NBs showed 
some change in morphology with electrical stimulation.  When printed, hASCs had significantly 
increased major length and responded to electrical stimulation with a decrease in area, similar to 
unprinted hASCs.  Moreover, when stained with DAPI, phalloidin, and TUJ1, NBs did not exhibit 
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polymerized actin or β-III-tubulin either before or after stimulation when printed through a 34g 
needle. However, printing NBs in medium, through a 32g needle, restored some actin and β-III-
tubulin expression, indicating that the printing process may be stripping cell adhesion molecules 
from the NBs during printing.  Similar experiments with hASCs, showed no change in actin 
polymerization compared to non-printed samples before or after stimulation through both a 32g 
and 34g needle, despite a more than eight times greater cell volume.  This indicates that bioprinting 
has a greater negative effect on NBs than hASCs.  To explore printing in hydrogel, NBs and hASCs 
were printed in 2%-8% CG hydrogel due to earlier observations that cells fail to spread in 3%-3% 
CG hydrogels.  While NB appear to spread in 2%-8% hydrogel, they do not respond to electrical 
stimulation.  Similarly, hASCs did not show spreading in 2%-8% CG hydrogel.  Finally, when I 
extended hASC culture to 6 days after printing or stimulation, I observed increased β-III-tubulin 
expression, indicating that bioprinting likely influences the differentiation of hASCs towards a neu-
ral lineage.  In addition, some hASCs printed through a 34g needle exhibited a neuron-like cell 
morphology after 6 days.  Overall, short exposure to shear stress may initiate differentiation of 
hASCs towards a neural lineage even without the use of neural culture or differentiation medium 
and a short overall culture time compared to typical two week differentiation protocols.  However, 
either the printing process or hydrogel properties seems to prevent cell spreading in the CG hydro-
gel ink. 
6.4 Recommendations 
6.4.1 Decreasing or Eliminating Hydrogel Slumping During Bioprinting 
As stated, I observed slumping in my bioprinted constructs.  I envision two approaches that might 
eliminate or decrease this issue.  If the temperature gradient can be increased the gel will move 
more quickly between temperatures, this is the basis of both approaches.  The first approach in-
volves the combination with a heated cell culture chamber maintained at or slightly above 37°C.  
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The use of a chamber would eliminate the issues with decreasing temperature in the z-axis.  How-
ever, due to premature gelation concerns, a cooled syringe jacket would also be necessary to main-
tain the hydrogel in the syringe at a non-gelled temperature.  This jacket would be more necessary 
with higher concentrations of chitosan and might be eliminated for gels with high gelatin content.  
The second approach is to take advantage of the gelation of gelatin at lower temperatures (See 
Figure 3.6) to maintain shape fidelity by printing the entire solution at or below room temperature 
then adding a pre-warmed, biocompatible, hydrophobic solution of medium to high viscosity.  I 
expect that adding a pre-warmed liquid will induce a higher temperature gradient to assist gelation 
of the hydrogel as temperature conduction through a liquid medium is much higher than through a 
gas.  The use of a hydrophobic liquid would prevent swelling of the hydrogel prior to gelation, 
while high viscosity would provide a buoyant force to counteract gravity.  Post gelation, the solu-
tion would need to be removed and replaced with cell culture medium.   
6.4.2 Improved Stimulation of Cells 
While I was able to observe cells during stimulation, condensate accumulating on the observation 
window and the petri dish surfaces sometimes made observation difficult.  This could be overcome 
by the introduction of a heated observation chamber instead of a heated build plate, which are 
commonly used for longer-term observation of cells.   
6.4.3 Differentiation of hASCs 
β-III-tubulin expression is widely used to indicate early neural differentiation.  I observed β-III-
tubulin expression in cells cultured for 6 days post printing.  However, I did not use neurodifferen-
tiation medium or neurobasal medium during culture.  The hASCs were maintained in normal ex-
pansion medium.  Utilization of a neurobasal medium might promote the growth of neuron-like 
cells.  In addition, most neural differentiation protocols are a minimum of 2-weeks (Table 2.5).  
Hence, extending the culture to two weeks, especially in neurobasal medium would be of interest 
and might demonstrate an increase number of cells expressing neural markers.  In addition, others 
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have stated that β-III-tubulin expression decreases in mature neurons and expression of other neural 
markers, such as PAX6 increases.  Hence, immunostaining hASCs cultured for a longer duration 
for PAX6 expression would provide more insight into the potential of shear induced differentiation 
for neural culture. 
6.4.4 Cell Spreading in CG Hydrogels 
The lack of observed cell spreading in CG hydrogels is a limitation of the ink.  I attempted to 
address the issue by exploring a 2%-8% chitosan-gelatin hydrogel in lieu of the 3%-3% hydrogel I 
initially investigated.  Lowering the chitosan concentration and increasing gelatin concentration 
leads to larger fibers with lower shape fidelity.  Moreover, I do not observe spreading of hASCs in 
these gels.  Whether this is a result of the printing process or the properties of the gel is unclear.  
First, I recommend exploring large bore needles to further reduce stresses on printed cells and 
determine whether spreading occurs in these larger fibers and extending culture time to allow for 
some degradation of the gel to occur post printing.  Based on previous work in our lab [147], which 
observed cell attachment and proliferation on CG hydrogels, the hydrogel likely does not lack at-
tachment sites.  It is also possible that my cell density is an issue and that exploring lower cell 
densities might result in spreading, especially for hASCs when some spreading may be observed 
by NB in 2%-8% hydrogel.  
6.4.5 Early β-III-Tubulin Expression 
The pathway responsible for β-III-tubulin expression due to bioprinting and electrical stimulation 
is unknown.  While some central nervous system proteins experience rapid expression changes, in 
as little as 30 min [148], to my knowledge, the rapid expression of β-III-Tubulin (3.5 hr or 210 
min), has not been explored.  It is interesting that there is such early evidence of differentiation, 
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OVERVIEW OF MATTER CONTROL SOFTWARE 
 
The Maker’s Tool Works MiniMax is operated by the MatterControl Software found on the desk-
top.  Below is the screen first seen when the software is opened.  Note that a print is already 
queued for printing; it is important this print is removed from the print queue.  If the software 
does not automatically connect to the printer the power button will say “CONNECT” instead of 




Tap “Settings and Controls” to display the screen below 
 
The manual controls are outlined in colored boxes:  
 Red:  Home to origin 
 Green:  Controls for movement of the print head in the y and z axis and the build plate in 
the x-axis, at bottom is the movement resolution per button press (Currently set to 0.1mm 
movement per press). 
 Blue:  Controls movement of the presser plate (CAUTION: The presser plate motor does 
not have hard or soft stops—nothing prevents the user, or control program, from damag-
ing the extruder—make sure to never move the presser plate up or down further than 
physically possible.  Pay special attention to the movement resolution and immediately 
cut power to the printer if the plate looks like it is going to run into the surrounding mate-
rial) 
 Yellow: removes power from the stepper motors allowing the user to move components 
by hand (useful if you cannot move the extruder or . 
 Purple: Hotplate/Bed Temperature controls: preheat sets the temperature to 37°C, any 
temperature can by typed into the target box.  Printing will not begin until the printer has 
reached the set temperature called for by g-code. 
 Cyan: The current position of the print head.  This is only accurate after homing the re-
spective axis (ie, if you press the Z home to origin, once the print head moves to the stop 








CREATING STRUCTURES WITH THE PYTHON SCRIPT 
 
The latest Python scripts are located on the desktop in the “New G-Code Generator 3” folder.  
“Runner.py” and “E-Stim Scaffold.py” can be run to directly create a scaffold. Other files are called 
by these main scripts and cannot be run directly, separating these python files is likely to break the 
system and cause errors.  To open a file, right click on it and select “Edit with IDLE.” 
Within the “runner.py” file, numerous code blocks create many different gcode files.  You can 
comment out or uncomment blocks you are interested in using  Format->Comment out Region and 
Format->Uncomment Region.  Commented regions appear in red and will be ignored by the code.  
Also, be aware that white space is important in Python, altering the number of spaces or tabs within 
files can cause compiler issues (the program won’t run). 
 





Here various parameters can be changed based on printing needs (make sure not to enter integers 
for floats, ie 2.0, not 2).  Typically, only the z offset will need to be changed.  To create the scaffold, 
either press F5, or choose Run->Run Module.  This will create a g-code file with the given name 
(bottom input in figure above).  You should see an additional window with the following infor-
mation: 
  
If you don’t see “Code Completed” and “ File Closed? True,” something likely went wrong in the 
code. 
CAUTION: Ensure that the amount of silver rod showing is greater than the total extrusion distance 
given in the code output (as shown in the figures above).  Nothing will prevent the printer from 
running the presser plate into the housing and damaging the printer! A collision will occur well 









Tells the print head how much to move in the z-axis be-
tween layers (does not equal the fiber height due to gelation 
and settling) 
Z offset 
Moves the Z=0 plane by the offset amount, critical for en-
suring the needle is barely above the print surface (petri dish 
or 6 well plate) 
Skirt radius 
Radius of concentric circle to print before printing the scaf-
fold.  Used to ensure flow is initiated and consistent prior to 
printing 
Number of skirts 
How many of the concentric circles to print, increased skirts 
increases the amount of printing done before printing the ac-
tual scaffold. 
Fiber spacing 
The center to center distance between fibers (shown in fig-
ure above) 
Number of fibers 
The total number of lines to print per layer (7 in the example 
cartoon above) 
Number of layers 
the number of consecutive layers, 5 in the example cartoon. 
Each successive layer will print fibers orthogonal to the pre-
vious layer 
Flow rate The flow rate of hydrogel through the needle 
Non-print velocity 
The velocity the print head (feed rate) moves across the bed 
when not printing (eg between printing each fiber layer) 
Print velocity 
The velocity the print head (feed rate) moves across the bed 
when printing (eg when printing each fiber layer) 
Bed temp The temperature to set the bed/hotplate  
Needle gauge Not important, legacy parameter 
Container present 
Boolean (T/F) whether to move up and down to avoid the 
walls of a container 
Print wait skirts 
Will print skirts after printing each layer.  Intended to de-
crease slumping by increasing the time before more material 
is deposited on the structure. 
File name 
Output filename, make sure it has .gcode.  File will always 








To print a structure, follow the following protocol:  This protocol includes steps for printing cells 
in sterile conditions. 
Make sure all needles have been autoclaved and that plates have been prepared to print on according 
to previous papers etc. 
1. Place the printer into the laminar, cell culture hood. And start the hood according to lab 
protocol (Do not plug the printer into power to prevent electrocution in following 
steps). 
2. Thoroughly mist the printer and cell culture floor with 70% isopropanol (IPA), do not un-
screw the spray cap too far or it will spray a jet which may cause damage to components. 
3. Leave the printer under UV for 40min to allow complete evaporation of IPA and for better 
‘sterilization’ 
4. Plug the printer in, zero the z-axis, then raise the print head ~60mm 
5. Subculture and count cells as per manufacturer protocol, aliquot 2x106 cells/ml to match 
final prepared hydrogel volume.  For example, for a 2-8 gel use 0.9mL of precursor solution 
and add 0.4mL of β-glycerophosphate (2GP) 




∙ 1.3𝑚𝐿 = 2.6 × 106𝑐𝑒𝑙𝑙𝑠 
6. Pellet aliquotted cells as per manufacturer protocol, then mix hydrogel: 
a. Aliquot ~2mL of precursor solution and centrigure for 90s at 14,600xg 
b. Remove supernatant to new tube with 1mL syringe (do this slowly) 
c. Mix 2Gp into precursor solution with custom sprinkler needle 
d. Centrifuge at 3000xg for 3-3/4-4 hydrogel, or 14,600xg for a 2-8 gel if lab temp is 
low, for 60s 
7. Aspirate media from pellet using a 1000µL pipetted, then use the mini-vortexer with a 
ribbed plate to re=suspend the minimum volume cell pellet. 
8. Add the pellet to the hydrogel with a 100µL pipette, pellet volume should be ~30µL (be 
careful not to create bubbles) 
9. Load the hydrogel into a syringe (do this very slowly so that the hydrogel is continuous 
without breaks), add a needle and either heat the solution for 5min for a 2-8 gel with cool 
ambient temperature, or cool the solution for 5 min for a 3-3 or 4-4 hydrogel with warm 
ambient temperatures in the lab. 
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10. Pre-Heat the Print Bed (See Appendix A for a description of the hotplate controls) 
11. Place the syringe into the print head and prime the syringe  
a. In the MatterControl software, ensure the extruder step is set to 1mm (lower red 
circle in following image; see Appendix A for a more detailed explanation of the 
software) 
b. Press the “E+” extrude button until the presser plate moves down and into contact 
with the syringe plunger 
c. Press the “E+” extrude button a few more times, pausing for at least 1s between 
presses.  When flow is observed from the needle, press the “E-” retract button once 
to remove pressure from the syringe 
 
12. By hand, position the print head over either an agarose filled petri dish, 6-well plate with 
coverslip, etc. (if the print head and bed won’t move, press the release button) use the “Z-
” button to move the print head down. 
a. Move the print head down to 10mm then move it down 1mm at a time (by changing 
the movement resolution; see Appendix A for explanation) until the needle is close 
to the print surface, then change the resolution to 0.1mm. 
b. Lower the print head until the syringe needle barely moves across the print surface 
without either cutting into the agarose or getting caught/scratching the coverslip. 
c. When the needle cuts into the agarose or catches, raise the print head with the “Z+” 
command until it no longer does so. 
13. Use the current z position (shown at the bottom of the matter-control screen) to set the z-
offset in the python script and run the script to create g-code for the current print (See 
Appendix B). 
a. Note: when first learning I recommend you use the “print minimum of 300,000 
cells (greater size and extrusion amnt)” code section which generates the file 
“1cmx1cm_grid.gcode.”  This file will work with an agarose filled 10cm petri dish. 
14. Drag and drop the file you just created into the MatterControl software (you should see the 
filename as shown below), move the print head up to clear whatever dish is being used 





CAUTION:  Ensure that the amount of silver rod showing is greater than the total extrusion dis-
tance given in the code output (see Appendix B for a more detailed explanation) 
15. Re-prime the syringe as described above, EXCEPT do not retract the presser plate, allow 
the syringe to continue flowing as you begin the print. 
16. Press Print.  The printer should begin moving immediately if you pre-heated the bed per 
step 10 
CAUTION:  Be careful where you put your hands when the printer is moving. 
17. Align the printing dish under the needle when it centers and begins lowering and  tape the 
dish in place (if necessary) 
18. Once the print completes, place the structure in the incubator to allow gelation (30-60min) 











Flow stops during printing 
 Solution may be too cold/hot, remove sy-
ringe and cool or heat 
 Needle likely also clogged or may be 
clogged independently.  Attempt printing 
with a new needle. 
3%-3% or 4%-4% solution will not print  Solution too warm, cool 
2%-8% solution will not print  Solution too cool, warm in incubator 
2%-8% solution too viscous to uptake with 
syringe after mixing 2GP 
 Ambient temperature not conducive to 
printing, preheat 2%-8% precursor solu-
tion prior to mixing 
Needle cuts or runs into print surface for part 
of print 
 Printer bed may not be level, re-level bed 
 Agarose may not have been poured on a 
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